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ABSTRACT 
 
The work presented in this dissertation addresses the optimization and application 
of a newly developed imaging modality, named photonic crystal enhanced microscopy 
(PCEM) for label-free detection of the surface attached biological samples. Photonic 
crystal, supporting guided-mode resonances and providing local optical modes, can 
enhance the light-matter interaction on its surface and thus used for label-free detection 
and biosensing. One dimensional photonic crystal surfaces are designed and utilized as a 
biosensor, and further integrated with an ordinary bright-field microscope. To 
demonstrate the validity of the photonic crystal biosensor, a three-dimensional modeling 
is developed and evaluated with finite-difference time-domain (FDTD) algorithm to 
predict and visualize the electromagnetic field redistribution upon the device surface. 
Applications of the photonic crystal enhanced microscopy are carried out for live 
cell imaging, nanoparticle detection and protein-protein binding detection. First, label-
free detection for live cell with PCEM imaging system is performed. Three different 
cellular phenomena are involved in this study, including cell adhesion, cell migration and 
stem cell differentiation. A novel imaging analysis software is developed to dynamically 
track the cell plasma membrane evolution. This traction software reveals mass 
redistribution with high resolution during cell migration which is previously difficult to 
evaluate quantitatively. Furthermore, both dielectric and metallic nanoparticles are 
examined and proved to be detectable as label-free detection using PCEM imaging 
system. Another novel imaging analysis software is developed to automatically count the 
number of nanoparticles attached on the sensor surface within the imaging field of view. 
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Finally, a newly developed detection modality for protein-protein binding is 
demonstrated through PCEM imaging system using nanoparticle as tags. This new 
detection modality can avoid the photobleach problem and may also hold the potential to 
detect ultra-low concentrations of protein in the future. 
In summary, photonic crystal biosensor and its associated imaging system with 
microscopy developed in this work show great promise to the label-free biosensing and 
bioimaging. Future work will extend the application of PCEM to broader research and 
application fields served as the next generation sensing modalities. 
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CHAPTER 1 
INTRODUCTION TO LABEL-FREE IMAGING AND PHOTONIC CRYSTAL 
BIOIMAGING 
 
In this chapter, we present the motivation for this work.  The need for accurate 
imaging tool stems from live cell imaging and biomarker detection problems.  Both these 
aspects, when addressed using currently existing methods, suffer from limitation 
hindering their practical use. The goal of this work is to propose and validate a simple yet 
versatile imaging modality able to overcome these limitations. We first describe the 
motivation in the context of live cell imaging as well as biomarker detection.  Then, we 
review existing imaging methods, focusing on label-free approaches.  Finally, we provide 
an outline of the work presented here. 
1.1 Motivation 
1.1.1 Live Cell Imaging 
Live cells are integrated not only structurally, but also functionally with their 
surrounding extracellular matrices (ECMs) in highly organized processes, which may be 
dynamically involved with thousands of proteins [1-4]. The complex interaction between 
cell and the ECM molecules is essential to regulate and mediate various cellular 
procedures, including cell adhesion, cell migration, and stem cell differentiation, etc. For 
instance, integrin [2], a type of transmembrane receptor, can cluster in some specific cell-
ECM adhesion sites (so called focal adhesions) to provide a dynamic link between the 
intracellular and extracellular environments.  Reorganization of the intracellular 
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cytoskeletal and ECM proteins enables signals (e.g. biomechanical, biochemical) to be 
propagated across the cellular membrane [5-12]. In this section, we review the cell-matrix 
interactions involved in the formation of cell adhesion, migration, and stem cell 
differentiation to potential future therapeutic approaches. 
Cell adhesion has been a popular research topic in the past several decades, 
mainly focusing on the binding of a cell to a substrate/surface, such as an extracellular 
matrix (ECM) or another cell [13-15].  It is critical for a live cell to utilize the cellular 
adhesion for maintaining its multicellular structure and function. Even though cell 
adhesion is a dynamic structure, it can withstand and exert forces on the ECM during a 
certain life time. A molecular complex at the cell focal adhesion (FA) site can gather over 
hundreds of different types of adhesion molecules, such as Src, FAK, talin, etc[16-18]. 
The cell adhesions connect cell cytoskeleton to ECM molecules through transmembrane 
proteins and may stimulate downstream signal transductions. Therefore, cell adhesions 
are one kind of mechanosensitive elements, which convert mechanical stimuli into 
biochemical responses by sensing and responding to environmental parameters (such as 
matrix components or rigidity). Due to the complexity of the cell adhesion process, the 
underlying mechanisms of cell–ECM or cell-cell adhesions remain unclear. 
Cell migration generally refers to the surface/substrate attached cells movement to 
a different location with crawling or blebbing motility [19-22]. The speed of cell 
migration is relatively slow, normally around a few um/minutes for cultured ordinary 
cells. Cell migration is a coordinated process of cellular membrane protrusions that 
regulated by the turnover of disassembly and reassembly of cell focal adhesion and the 
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dynamics formation of actin filaments in the migration frontier [20, 23]. The traction 
forces are generated during this complex process by the activity of motor proteins (such 
as myosin) for cells to seize on the ECM molecules and move the whole cell body [24]. 
External stimuli from the surrounding environment can influence cell migration via 
intracellular biochemical signals transduced into the cytoskeleton network through the 
interactions of transmembrane proteins with ECM molecules [25]. During migration, the 
morphological features of moving cells can vary significantly[26]. For example at one 
extreme, round and highly protrusive or blebbing cells (such as lymphocytes and cancer 
cells in some environments) can migrate with high speed using weak adhesions [27, 28]. 
On the other hand, highly spread cells (such as fibroblasts and endothelial cells) have 
many large and strong adhesions and migrate relatively slowly, while their migration is 
often referred to as being mesenchymal [29]. In reality, both the external factors, such as 
substrate compliance or dimensionality, and intrinsic factors, such as the contractility of 
the cells, can alter the migration modes. Therefore, understanding the mechanism of cell 
migration and the influencing factors is essential to the development strategies of many 
novel therapeutic methods, and may impact tissue repair, stem cell therapeutics, cancer 
metastasis preventing, as well as drug development, just to name a few. 
Stem cells have the ability to generate mature cells with a type of specific tissue 
through differentiation and also have the ability to perpetuate themselves through self 
renewal [30-35]. Stem cell differentiation is a critical process for development of 
multicellular organism and can occur during embryonic development, wound healing, or 
cancer development, etc. Cellular differentiation is a transition from one pattern of gene 
expression switching to another one and thus is regulated by the gene regulatory network. 
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A cascade of signaling events, often initiated from the extracellular environment and 
propagated through the transmembrane molecules and cytoskeletons, can influence the 
cell differentiation fate [36-39].  Once the signal reduction triggers the cellular 
differentiation, a series of dramatic changes in the cell will occur, such as gene 
expression, morphology, metabolic activity, etc. However, the cellular differentiation and 
the regulation signal network are complex processes highly evolving through with 
changes in the environment and are still largely unknown. Therefore, understanding the 
cellular differentiation process as well as the regulation factors holds great promise for 
the future of regenerative and translational medicines. 
1.1.2 Cancer Biomarker Detection   
Each year, more than ten million people are diagnosed with cancer globally [40]. 
Although there has been significant progress in understanding and treatment of cancer 
over the past decades, cancer still causes more than five million deaths (more than 10% 
of all human deaths) every year and thus remains one of the highest death-rate diseases. 
One reason causing the high death-rate of cancer is late diagnosis, since cancer grows 
uncontrollably from the inner part of the organs and cannot be efficiently recognized by 
the human body immune system. In an advanced cancer development stage, cancer cells 
often invade surrounding tissues and can also metastasize from the primary site to other 
parts of the body.  
Every cell type, including cancer cell, has a unique molecular signature (referred 
to as biomarkers) [40-44]. Through secretion, cancer cells may release many DNA, RNA, 
proteins, lipids, or other macromolecules into the extra-cellular fluid in the human body. 
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Some of these released products, often in very low concentrations, can end up in the 
bloodstream circulation and hence serve as potential serum biomarkers. The cancer 
biomarkers contain useful information on most of the physiological process in cancer 
cells, cancer tissue microenvironment and cancer cell-host interaction, and the level and 
activities of cancer biomarkers in blood circulation are identifiable with different features 
at different development stages. Therefore, cancer biomarker can be an important 
biological indicator of cancer status and progression for the physiological processes of 
the cancer cell or tissue (such as disease-related biomarkers), or pharmacological 
responses to a clinic therapeutic intervention (such as drug-related biomarkers).  
Despite growing research and fruitful achievements in cancer therapy, nearly half 
of people who had received treatment for invasive cancer died from cancer or the 
treatment each year. It is well known that the chance of being cured of cancer increases 
with earlier cancer detection and treatment. Nowadays, however, only a few cancer 
biomarkers are available to evaluate and stage cancer in routine clinical practice, 
although there are many notable accomplishments in the research field of cancer 
biomarker detection [45-48]. One major factor preventing routine clinical evaluation is 
the difficulty to detect cancer biomarkers due to their low concentration in the blood 
stream and their high variability across individuals. Consequently, it causes low 
sensitivity as well as low prognostic and predictive value in biomarkers detection 
methods [49]. Thus, there is a great need to develop high sensitivity and inexpensive 
method to detect the circulating cancer biomarkers. 
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1.2 Label-free Imaging  
The imaging contrast of a live cell without labeling under a conventional bright-
field microscope is infinitesimal since the effective refractive index of a normal live cell 
is about 1.35~1.37, while that of water (as background) is 1.33 in the wavelength range 
of visible light. Therefore, labels employing dyes or fluorescence have been used to 
enhance visualization of detecting the presence of a particular biomolecule or cell to 
which the biomarkers are conjugated. These labeling methods for detecting biomolecules 
or cells are powerful and are supported by standardized infrastructure across industries. 
In addition, dielectric-based devices have also been used in an attempt to improve the 
detection sensitivity. For instance, total internal reflection fluorescence (TIRF) is a well-
established technology in which light is coupled into a waveguide and thus fluorophores 
can be excited within the evanescent field on the device surface [50-52].  The incident 
light can be incoupled with a grating or a prism and then propagated along the waveguide 
through total internal reflection, where the biological sample placed on the top side of the 
waveguide functions as the cladding. TIRF-based microscopy can selectively visualize 
the cell-matrix interface with high axial resolution since it only excites the fluorophores 
within the evanescent field on the device surface, and thus diminishes the background 
fluorescence which would otherwise scatter and absorb signal from other components in 
the cellular media.  Therefore, the signal-to-noise ratio of the TIRF microscopy can be 
significantly improved with inherent spatial discrimination.  
In spite of its widespread use, labeled detection has several inherent drawbacks 
caused by the natural properties and physical linking of the label itself.  For example, 
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labels can possibly block the binding sites of the probe or target proteins, modify analyte 
conformation, and induce steric hindrance in molecular detections. Labels can also be 
toxic in live cell imaging and intrinsically alter cell behaviors, functionalities or signal 
pathways. Moreover, fluorescent tags are subject to quenching and can be photobleached 
very quickly, which may cause difficulty to provide long-term kinetic information.  In 
addition, finding and producing an appropriate label which can function stably and 
uniformly across a biosystem can be costly and tremendously time consuming [53].  
Therefore, although it is challenging, eliminating the label from the detection assays 
while still maintaining the high sensing sensitivity is the ultimate vision in the research 
field of bioimaging and detection, since it will provide noninvasive probing, improve the 
detection accuracy, limit conformation modifications and provide long-term kinetic 
information.  
1.2.1 Label-free Biosensor 
Label-free biosensors are an emerging class of biosensing and detection methods 
[54]. Namely, the molecules of interest in label-free detection are not labeled or altered 
and thus can be detected in their natural forms. Label-free detection can quantitatively 
reveal the binding affinity, specificity, and long-term kinetics of the biological elements. 
Label-free detection can be implemented in schemes that utilize a transducer to probe 
some properties of the interested analyte, such as electronic charge which can be 
determined by field-effect transistor-based or electrochemical sensors, mass which can be 
measured by piezoelectric or surface acoustic wave devices, or dielectric permittivity 
which can be sensed by evanescent optical fields [55, 56].   
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Label-free optical biosensors are especially attractive since the biochemical 
interactions can be interrogated from afar (as long as within the detection zone) without 
any direct physical connection to the optical sensor itself, which provides flexibility for 
sensor formats and enables the use of large sensor arrays [57-59]. Fundamentally, the 
sensitivity of a label-free optical biosensor is determined by the strength of the light-
matter interaction atop of the sensor surface. Generally, electromagnetic evanescent fields 
are generated on the top of label-free optical biosensors and form the active detection 
zone. They can be utilized to examine the interaction of the light with the absorbed 
biomolecules. A change of the dielectric permittivity caused by the biological elements 
within the detection zone, e.g. surface attachment of proteins or cells, will lead to a 
corresponding variation in the resonance wavelength or intensity of the reflected or 
transmitted light.  The exponential decay of the evanescent fields results to a penetration 
depth of around 200 nanometers in the active detection zone atop of the optical sensor 
surface. The resulting scheme of near-surface detection is indeed ideal for monitoring the 
interactions of biological elements at the transducer surface, including nucleic acids, 
proteins, cell-ECM, while minimizing the bulk solution interferences. Besides, the optical 
transducer has no inherent selectivity, while the sensing selectivity is provided by the 
surface chemistry or capture biomolecules immobilized atop the sensor surface. This 
supplies a broad application range for label-free optical sensor which can be used for 
most of the biomolecules or live cells. 
1.2.2 Surface Plasmon Resonance Biosensor 
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Among many other optical sensing modalities, including resonant mirrors and 
ellipsometry, surface plasmon resonance (SPR) is the most popular and widely studied 
label-free optical sensing technique [60-63], which was first demonstrated for biosensing 
by Liedberg et al. in 1983 [64]. The surface plasmons, which are resonant oscillations of 
the free electrons at the interface between dielectric and metal materials (e.g. gold), can 
be excited when polarized incident light is diffracted at the angle of total reflection. The 
total reflection angle relies on the refractive index of the surrounding media within the 
decay length of that electromagnetic evanescent wave. When the wave vector of the 
incident light matches that of the surface plasmon, the energy extraction appears as a 
depression in the reflected spectrum at a given wavelength and incident angle. Therefore, 
the target analyte can be sensed in real time by interacting with the incident light, 
modifying the dielectric permittivity and correspondingly the excitation conditions of the 
surface plasmon atop of the metallic layer. SPR is a very powerful tool though it also has 
limitations, such as the cost of the system and its complexity (due to the need for 
precision optical and alignment components). Besides, SPR-based biosensing and 
bioimaging methods may suffer from the broad spectral width due to the intrinsic 
property of the metal plasmon resonance which leads to low spectral resolutions in 
biosensing. Moreover, the large lateral propagation of surface plasmons (e.g. generally on 
the order of 100 µm) may restrict the spatial resolution of the SPR-based imaging.    
1.2.3 Photonic Crystal Biosensor 
A novel photonic crystal optical biosensor has recently been demonstrated for 
label-free detection of biochemical interactions [65-72]. Photonic crystal is a periodic 
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multi-layer dielectric structure with optical properties that vary with sub-wavelength 
periodicity in one, two, or three dimensions. Photonic crystal biosensor demonstrates a 
narrow-band reflection with nearly100% reflection efficiency at the resonance 
wavelength. It also exhibits a strong optical confinement of incident light into an 
infinitesimal volume and thus enables the detection in nanometer scales.  
Photonic crystal biosensor has been utilized to detect surface attached biological 
analyte and exhibited a high detection sensitivity for mass density and a large dynamic 
range [73]. In addition, photonic crystal sensor has also been employed to detect gas, 
temperature, pressure, stress and humidity, to name a few. Materials commonly utilized 
for photonic crystal fabrication are heteropitaxial layers (e.g. AlGaAs/GaAs), III-nitride 
compound layers or dielectric layers (e.g. Si3N4, TiO2, SiO2). Recently, organic 
compounds and polymers (e.g. UV curable polymers) have attracted much attention due 
to the simple and low cost fabrication processes and capability for mass-scale production. 
Moreover, photonic crystal biosensors can be incorporated into standard microplates (e.g. 
96-well microplate) for compatibility with existing fluid handling systems as well as high 
throughput, multiplexing detection system. In summary, photonic crystal biosensor has 
demonstrated great promise as the next generation biosensing technique. 
1.3 Research Outline 
The ultimate goal of this research is to develop and utilize photonic crystal 
enhanced microscopy system for biosensing and bioimaging, including detection of live 
cell, nanoparticle and protein-protein interaction. Chapter 2 describes the fundamental 
physics and design of the photonic crystal biosensor followed with a computer-based 
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modeling, as well as characterization of the biosensor. The working principle of the 
photonic crystal enhanced microscopy system for bioimaging is also introduced in this 
chapter. Label-free imaging for live cell with photonic crystal enhanced microscopy, 
including cell adhesion, cell migration, and stem cell differentiation, is addressed in 
Chapter 3. This chapter also describes the imaging analysis software which was 
developed to study the spatiotemporal dynamics of cell boundary evolution during 
migration. Chapter 4 explores the label-free detection for nanoparticles with photonic 
crystal enhanced microscopy. This work is extended in Chapter 5 and a novel detection 
method utilizing the nanoparticles as tags to probe the protein-protein interactions is 
introduced in this chapter. Finally, Chapter 6 summarizes the thesis and provides the 
future outlook for this research.  
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CHAPTER 2 
PHOTONIC CRYSTAL ENHANCED MICROSCOPY 
 
This chapter describes the photonic crystal imaging used in this work.  As 
mentioned previously, photonic crystal has advantages when compared to existing label-
free methods, specifically higher spectral resolution and potentially higher spatial 
resolution (because of the lesser amount of lateral propagation).  This makes photonic 
crystal imaging a promising candidate to achieve our goals in imaging of both live cells 
and protein-protein binding.  This chapter first briefly introduces the historical 
background for photonic crystal microscopy.  Then, we describe the optics theory 
necessary to understand the biosensor.  Further, we present the basics of photonic crystal 
biosensor, including the periodic subwavelength grating structure, its effect on guided-
mode wave propagation, as well as the photonic crystal biosensor modeling.  Finally, the 
actual design and fabrication of the biosensor and the development of photonic crystal 
based imaging system are discussed. 
2.1 Introduction 
Anomalies in periodically modulated nanostructures, initially discovered by 
Wood in 1902 [74] as an anomalous interaction of light with dielectric gratings 
structures, have attracted much attention in the last several decades. The structures of 
resonant anomalies in waveguide gratings had later been demonstrated with a 
subwavelength modulation in refractive index along one dimension [75, 76]. This 
nanostructure can function as optical filters producing complete exchange of energy 
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between bi-directional propagating diffracted waves with arbitrarily low line widths and 
smooth line shapes [77]. This guided-mode resonance is a result of possible guided 
modes propagating with a periodic modulation, which allows phase-matching of 
externally incident radiation into modes that can be re-radiated into free space. Lately, 
guided-mode resonances have also been shown in 2D photonic crystal (PC) slabs [78-80] 
and crossed gratings [81, 82]. 
Photonic Crystal (PC) biosensors have recently been demonstrated as a highly 
versatile technology for a variety of label-free assays including high-throughput 
screening of small molecule–protein interactions, characterization of protein–protein 
interactions, and measurement of cell attachment modulation by drugs [53, 65-71]. A PC 
biosensor is a sub-wavelength grating structure consisting of a periodic arrangement of a 
low refractive index material coated with a high reflective index layer. By measuring the 
resonant peak wavelength value (PWV) on a pixel-by-pixel basis over a PC surface, an 
image of cell or protein attachment density may be recorded. PWV images of the PC may 
be gathered by illuminating the structure with collimated white light through the 
transparent substrate, while the front surface of the PC is immersed in aqueous media. 
The advantages of PC-based surfaces for cell or protein attachment imaging are 
compelling. As a label-free technology, cell or protein attachment to a PC sensor is 
measured without the use of dyes or stains, so a population of cells or proteins can be 
measured repeatedly without disrupting their culture environment. The detected output 
signal is highly quantitative, providing measurements that are repeatable between 
sensors, instruments, and laboratories without photobleaching.  
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PC biosensors can be fabricated from inexpensive materials and require only low 
intensity illumination from beneath the sensor, and there is no need for electrical or 
physical contact between the sensor and the detection system. Besides, the PC biosensors 
can be utilized in a reflection mode, so the illumination light does not pass through the 
cell body, the cell media, or the liquid–air meniscus of a microplate well. Therefore, it 
efficiently avoids the scatter problem which could happen in transmission mode. 
Furthermore, the PC biosensor strictly limits lateral propagation of resonantly coupled 
light, enabling imaging-based detection with resolution sufficient for measuring subtle 
variations in cell adhesion strength within a single cell, without needing to pre-tune the 
sensor to a particular resonant coupling condition, as in Surface Plasmon Resonance 
imaging (SPRi). In summary, PC biosensor imaging provides information that is 
fundamentally different than that provided by conventional optical microscope, as the 
sensor responds to local variation in cell or protein attachment strength to the transducer 
surface. The sensor can be prepared with a variety of surface functionalizations (such as 
matrix coatings, antibodies, and peptides) and thus can be used as a tool for measuring 
how cell or protein attachment to surfaces is modulated by drugs, growth factors, or other 
environmental factors. 
This chapter describes the theoretical background and the development of the 
photonic crystal biosensor used in this work.  As discussed earlier, existing biosensors 
aiming at imaging nano-structures as well as live cells face limitations hindering their 
practical use.  Label-based such as fluorescence imaging is degraded by the 
photobleaching effect and limits the length of imaging sessions (which prevents the study 
of medium-to-large time scale mechanism.  Methods based on optics can address these 
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issues, but are also limited by imaging contrast and sensitivity.  In order to circumvent 
the limitations of existing biosensors, our lab previously developed a Photonic Crystal 
Enhanced Microscopy (PCEM) [66, 83] which is used as a foundation for this work.   
2.2 Photonic Crystal Biosensor  
2.2.1 Physics of Photonic Crystal Biosensor 
A photonic crystal biosensor, as shown in Figure 2.1, has a grating structure in a 
sub-wavelength range of the illumination light. The sensor consists of a periodic grating 
of a low refractive index material coated with a high refractive index layer, while the 
grating and the high index guidance layer are the key components.  The grating enables 
phase matching of external radiation to the modes supported by the photonic crystal, and 
symmetrically gives rise to the leaky nature of these modes by enabling re-radiation of 
the confined light.  When the PC is illuminated with a broadband light source at normal 
incident angle, high order diffraction modes couple light into and out of the high 
refractive index layer, destructively interfering with the zeroth-order transmitted light. 
For off-normal incident light, a single order couples to a single leaky mode.  This 
phenomenon can be observed in far field as a significant dip in transmission or a peak in 
reflection for illumination wavelengths and angles that satisfy the resonance condition:  
,
2
)sin(
2







m                                             (1-1) 
where λ and θ represents the wavelength and illumination angle of the incident 
light, respectively; m denotes the diffraction order of the modes; Λ describes the period 
of the grating structure; and β is the real part of the propagation constant of the guided 
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mode. Phase matching by the periodic structure to the reflected and transmitted zeroth 
orders enables extraction of energy from the leaky waves. At a particular resonant 
wavelength and incident angle, complete interference occurs (no light is transmitted) and 
it yields a sharp resonant reflection peak with nearly 100% reflection efficiency.   
The spectral location of peak reflection, named resonant wavelength, can be 
modulated by the addition of biomaterial upon the PC surface within the range of the 
strongly confined electric field (evanescent field).  Hence, bulk refractive index variation 
of the medium atop the sensor surface will result in a shift of the resonance wavelength to 
a higher wavelength, as will any thickness or density changes of a surface-bound 
biomolecular layer.  Thus, photonic crystal biosensor enables quantitative measurement 
of molecular adsorption or conformation change in the evanescent field at the sensor 
interface by converting the nanoscale changes into a readily detectable optical signal.   
The electromagnetic standing wave that is generated at the PC surface during 
resonant light coupling inhibits lateral propagation, thus enabling neighboring regions on 
the PC surface to display a distinct resonant wavelength that is determined only by the 
density of biomaterial attached at that precise location. By measuring the resonant peak 
wavelength value (PWV) on a pixel-by-pixel basis over a PC surface, an image of 
biomaterial (such as cell or protein) attachment can be acquired.  PWV images of the PC 
can be acquired by illuminating the structure with low intensity collimated broadband 
light (through the transparent substrate), while the front surface of the PC biosensor can 
be immersed in aqueous media.  
2.2.2 Photonic Crystal Biosensor Modeling 
To predict the local reflectance spectrum and to visualize the distribution of 
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electromagnetic fields on PC surface, we applied the Lumerical Finite Difference Time 
Domain (FDTD) [84] computer simulations of the PC structure (Figure 2.2).  Two 
periods of the device are simulated, with periodic boundary conditions applied to the 
perpendicular to the grating structures.  Using the physical dimensions of the fabricated 
device to specify the modeled structure, FDTD predicts a resonant reflection wavelength 
of λ = 620 nm and a reflection efficiency I = 96%.  This result can guide the design of the 
PC and gives an estimate of the expected contrast that can be observed in the conditions 
of the simulation.   
2.2.3 Photonic Crystal Biosensor Fabrication 
The PC sensors used in this study can be fabricated using a low-cost nanoreplica 
molding approach (Figure 2.3) that has been described previously.  Briefly, a silicon 
wafer molding template with a negative volume image of the desired PC grating structure 
(period = 400 nm, depth = 120 nm) was fabricated using deep-UV lithography and 
reactive ion etching. Liquid UV-curable epoxy was pressed between a glass cover slip 
(0.17 mm thick) and the silicon wafer, and was subsequently cured to a solid using a high 
intensity UV lamp.  The hardened epoxy preferentially adhered to the glass substrate and 
was peeled away from the silicon wafer, leaving a replica of the silicon mold. A thin 
TiO2 layer (t ~ 60 nm) was deposited via reactive RF sputtering (PVD 75, Kurt Lesker) 
providing the high-refractive index coating.  Figure 2.4 presents a scanning electron 
micrograph of the replica-molded sensor after dielectric coating that shows excellent 
uniformity across the PC surface.  The grating height is ~60 nm and the roughness on PC 
surface is 4.3 nm ± 1.0 nm (top) and 6.6 nm ± 1.4 nm (gap between the teeth) for an area 
of 100 nm × 100 nm, as measured by atomic force microscope (AFM). The PC is 
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designed to resonantly reflect a wavelength of λ ~ 620 nm, when covered by aqueous 
media. 
2.2.4 Photonic Crystal Characterization 
The ability of the PCEM to measure peak shifts of the resonance wavelength in 
the bulk refractive index of the cell media was performed to calibrate for cell attachment 
demonstrations. The PC surface was exposed to deionized (DI) water (n = 1.333) and 
subsequently exposed to isopropyl alcohol (IPA) (n = 1.377). The individual pixel atop 
PC surface in a PWV image demonstrates high reflection efficiency and narrow resonant 
reflection bandwidth, and the PWV shift yielded a bulk refractive index sensitivity of 
Δl/Δn = 102 nm/RIU (refractive index unit). With the PC surface exposed to cell media 
(Ham's F12 media, Invitrogen) in a PDMS well attached on the PC under mammalian cell 
culture condition (T = 37 ºC and 5% CO2), a series of PWV images were acquired over a 
12 hour period to demonstrate PWV stability. The average PWV shifted about 0.12 nm 
over 12 hours, and the standard deviation of PWV within an image (512×512 pixels) of a 
PC was 0.09 nm.   
2.3 Principle of Photonic Crystal Enhanced Microscopy (PCEM) 
A schematic diagram and a photo of the PCEM instrument are shown in Figure 
2.6 and 2.7, respectively.  The system is built upon the body of a standard inverted 
microscope (Carl Zeiss Axio Observer Z1). In addition to ordinary bright field imaging, a 
second illumination path is provided from a fiber-coupled broadband light-emitting diode 
(LED) (Thorlabs M617F1, 600 < I < 650 nm).  The fiber output is collimated and filtered 
by a polarizing beamsplitter cube to illuminate the PC with light that is polarized with its 
electric field vector oriented perpendicular to the grating lines.  The polarized beam is 
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focused by a cylindrical lens (f = 200 mm) to form a linear beam at the back focal plane 
of the objective lens (10× or 40×, Zeiss).  After passing through the objective lens, the 
orientation of the line-shaped beam is rotated to illuminate the PC from below at normal 
incidence.  The reflected light is projected, via a side port of the inverted microscope and 
a zoom lens (1.6×), onto a narrow slit aperture at the input of an imaging spectrometer.  
The width of the adjustable slit was set to 30 nm for the work reported here.  Using this 
method, reflected light is collected from a linear region of the PC surface, where the 
width of the imaged line, 1.2 µm, is determined by the width of the entrance slit of the 
imaging spectrometer and the magnification power of the objective lens.  The system 
incorporates a grating-based spectrometer (Acton Research) with a 512×512 pixel CCD 
camera (Photometrics Cascade 512).  The line of reflected light, containing the resonant 
biosensor signal, is diffracted by the grating within the spectrometer (300 lines/mm) to 
produce a spatially resolved spectrum for each point along the line.  Therefore, each pixel 
across the line is converted to a resonant reflection spectrum (Figure 2.8 (a)), containing a 
narrow bandwidth (Δλ ~ 4 nm) reflectance peak from the PC.   
The PWV of each peak is determined by fitting the spectrum to a second order 
polynomial function, and then mathematically determining the maximum wavelength of 
the function.  By fitting all 512 spectra, in a process that takes 20 ms, a line comprised of 
512 pixels is generated that represents one line of a PWV image of the PC surface (Figure 
2.8(b)).  With a 10× objective lens and an effective magnification of 26×, each pixel in 
the line represents a ~0.6 µm width on the PC surface and 512 such pixels cover a total 
width of ~300 µm (x dimension).  To generate a two-dimensional PWV image of the PC 
surface, a motorized stage (Applied Scientific Instruments, MS2000) translates the sensor 
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along the axis perpendicular to the imaged line (y dimension) in increments of 0.6 
µm/step.  Using this technique, a series of lines are assembled into an image (Figure 2.8 
(c)) at a rate of 0.1 sec/line and the same area on the PC surface can be scanned 
repeatedly.  Each image is comprised of 512 by n pixels, where n can be selected during 
each scan session, and each pixel represents a 0.6×0.6 µm
2
 region of the PC surface.  A 
biosensor experiment involves measuring shifts in PWV and/or shifts in the resonant 
Peak Intensity Value (PIV).   
2.4 PCEM System Optimization 
The system developed reported in [66, 83] has been improved as part of this work 
in order to adapt to the new type of applications.  We list here some of these 
improvements and how they pertain to specific imaging tasks. 
2.4.1 Fast Acquisition Software 
In order to allow for dynamic acquisition of live cells, the imaging software had 
to be accelerated.  The existing system was limited to acquiring a single frame per 
minute, which limits the ability to image live cells with sufficient frequency to observe 
displacement and attachment (these phenomena are best observed with a time period on 
the order of seconds between frames).  A few additions to the existing software were 
included to the existing code in order to reduce acquisition time: 
1) The data format on disk was changed from text to binary.  With pixel values on 
the order of 10
5
 (5 digits), using a binary format reduces the size of the output 
files written to disk (by a factor 2 to 3) thus accelerating file writes and does not 
require extra conversions (although this effect is minimal). 
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2) Typical scans using the existing software were performing image acquisition 
(using the line scan approach described earlier), then waiting for the current frame 
to be written to disk before continuing with the scan.  The write time can be 
overlapped with acquisition of the next frame by using a double buffered system.  
As described on Figure 2.9, the system starts with both buffers empty and 
requests a buffer whenever a frame is to be acquired.  As soon as a line scan is 
terminated, a trigger is sent to a writer thread responsible for generating the output 
file.  In the mean time, if the second buffer has been written to disk, it can be used 
to acquire the next frame instantaneously. 
3) Finally, the software has been augmented to allow for imaging of multiple regions 
of interest within the field of view.  Instead of performing a large scan of the 
whole field of view (512
3
 samples), acquisition time can be reduced by scanning a 
few subregions with less samples. 
2.4.2 Combining Bright-field Imaging 
In order to visualize simultaneously PC spectra images and bright-field images, 
the imaging acquisition software was augmented to control a separate bright-field 
camera.  Illumination for this bright-field camera originates from a different light path, 
which is also controlled by the imaging acquisition software.  PC spectra scans and 
bright-field scans are interleaved for each frame.  The bright-field imaging can be useful 
for confirmation of the cell existence, position or morphology change.  
The bright-field image is taken by a separate camera in an independent output 
light-path, tuning by a rotation wheel with mirrors rotating between the label-free 
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imaging light-path and bright-field light-path. The bright-field imaging can be useful for 
confirming the cell status during dynamic detection of live cell imaging. The bright-field 
acquisition was absent from the original software and thus had to be implemented and 
integrated into the acquisition software (in C # language). The acquisition sequence is 
setup as follows: first a label-free image is acquired using a line scan (with the imaging 
stage moved line by line); then the imaging stage moves back to the center of the field of 
view; the reflector is closed to block the strong light from LED; the rotation wheel is 
tuned to the bright-field imaging light-path; finally the bright-field imaging camera takes 
a bright-field image. To prepare for the next acquisition, the rotation wheel is turned back 
to the label-free light-path. The series of label-free images and bright-field images can be 
taken sequentially.  
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2.5 Figures 
 
 
 
Figure 2.1  Schematic Diagram of Photonic Crystal Biosensor. 
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Figure 2.2  Computer simulations with FDTD of  (a) reflection and (b) near field 
electric-magnetic distributions of photonic  crystal surface. 
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Figure 2.3  PC Biosensor Fabrication Process. (a) The process begins with depositing a 
thin layer of liquid UV epoxy polymer between a Si wafer template and a glass substrate. 
(b) The epoxy is converted to a solid with UV light exposure. (c) The template is peeled 
away and the grating pattern is transferred to the glass. (d) A thin layer of sputter-
deposited TiO2 film is applied over the grating structure. (e) Scanning electron 
micrograph of the PC surface.  Inset: Zoomed in tiled SEM image. (f) Photo of a PC 
fabricated on a glass cover slip.  
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Figure 2.4  Scanning electron micrograph of the PC surface.  Inset: Zoomed in tiled SEM 
image.   
 27 
 
 
Figure 2.5  Photo of a photonic  crystal biosensor fabricated on a glass cover slip.  
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Figure 2.6  Instrument schematic of the photonic crystal enhanced microscopy (PCEM). 
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Figure 2.7  A lab photo of the photonic crystal enhanced microscopy (PCEM). 
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Figure 2.8  PCEM Data Acquisition. (a) Example spectrum at resonance wavelength. (b) 
Normalized spectrum image (surface plot). (c) PCEM system acquired 3D spectrum data. 
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Figure 2.9  Double Buffered Imaging Acquisition for Fast Scan in Photonic Crystal 
Enhanced Microscopy System. 
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CHAPTER 3 
LABEL-FREE IMAGING FOR LIVE CELL USING PCEM  
 
3.1 Background and Motivation 
The extracellular matrix (ECM) is composed of molecules secreted by cells which 
can provide structural and functional support to the cells imbedded in this environment. 
The interactions between cells and their ECMs are critical for the mediation and 
regulation of many cellular activities, such as adhesion, proliferation, communication, 
differentiation, etc [1, 2]. Conventional methods for measuring and characterizing these 
interactions generally require labeling cells with stain or fluorescence dyes/proteins. The 
labeling methods, however, may be cytotoxic to the cells, vary the conformation of the 
target proteins in cells, or suffer from the fluorescence photobleaching effect. Therefore, 
it may complicate the study of cell behavior and function [85, 86]. 
Label-free microscopy imaging approaches have been developed to address the 
above challenges and can be used to investigate the cellular-ECM interactions [87-89]. 
Typically, a biosensor transducer surface (such as thin metal or photonic crystal layer) is 
utilized in label-free microscopy technologies to generate an electromagnetic signal, 
including electrical and optical signal. This signal can possibly be modified by the 
intrinsic physical properties (such as dielectric permittivity) of the biological material on 
the top of the transducer surface. The selectivity of the label-free biosensor is generally 
broad owing to the fact that it is determined by the surface chemistry rather than the 
sensor itself. Surface Plasmon Resonance imaging (SPRi) [90] is one of the popular 
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label-free methods that can measure cell attachment. The principle of SPRi, which 
utilizes electromagnetic surface waves propagating (parallel to the dielectric/metal 
surface) on a thin planar metal film (such as gold), is to detect the permittivity change by 
the surface reflected light with a certain angle under specific resonance conditions. 
However, SPRi maybe in practice for live cell imaging. For example, the lateral 
propagation distance of SPRi is typically more than several tens of microns, which may 
have a degrading influence on the spatial resolution [91]. Both incidence and reflection 
light paths pass through the cell body which may cause scattering in the reflected light 
and also lead to complicated data interpretation [92, 93].  
In this work, we demonstrate the dynamic label-free imaging using photonic 
crystal enhanced microscopy (PCEM) to measure the live cell surface attachment profile 
during adhesion, migration and differentiation. As mentioned earlier, this imaging system 
incorporates the photonic crystal (PC) biosensor with an ordinary microscope system and 
a spectrometer to generate the reflection spectrum of the PC, while the output 
spectrograph is collected with a CCD camera. The PCEM system utilizes the evanescent 
field atop of the PC as the sensing zone (with a penetration depth of ~200 nm), and can 
quantitatively measure the dynamic cellular material change and cell–ECM interactions 
(within the sensing zone). It can also be applied with substrates functionalized with 
different types or concentrations of ECM molecules, and thus can be broadly used in 
many extracellular conditions. Furthermore, the PCEM is integrated with an incubator 
which maintains the normal cell culture condition. Besides, as a label-free imaging 
system, the PCEM does not suffer from the limitations of fluorescence photobleaching, 
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and therefore enables long-term monitoring of cell attachment over substantial time 
scales (such as hours, or up to days). 
3.2  Material and Methods 
3.2.1 Cell culture  
1) 32D Cell 
A myeloblast-like cell line (32D stem cell), which is an interleuin-3 (IL-3) dependent 
murine myeloid progenitor cell line, was purchased from ATCC. Stable cultures of the 
32D cell were maintained in RPMI 1640 medium with 2 mM L-glutamine adjusted to 
contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM 
sodium pyruvate supplemented with 10% heat-inactivated fetal bovine serum and 10% 
mouse WEHI-conditioned medium. The differentiation of 32D cell into neutrophilic 
granulocytes is by removal of IL-3 and injection of granulocyte-colony stimulating factor 
(G-CSF) to the 32D growth medium. 
2) ASC cell 
Porcine adipose Stem Cells, a type of mesenchymal stem cells (MSC), were obtained 
from Matt Wheeler's group in Animal Science. Stable cultures of ASC cells maintained 
in low glucose DMEM supplemented with 10% FBS. For osteogenic induction, they were 
cultured in low glucose DMEM supplemented with 10% FBS, 0.1 μM dexamethasone, 
10 mM beta-glycerophosphate, and 50 μM ascorbic acid. 
3) mHAT cell 
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Murine dental stem cells (mHAT) were attained from the Harada Lab. Stable cultures of 
the wild type HAT cell were maintained in Dulbecco's Modified Eagle Medium 
supplemented with B-27 serum free supplement (Invitrogen), 20 ng/ ml bFGF and 20 ng/ 
ml EGF (Peprotech).  
3.2.2 Stem cell differentiation 
Induce the ASC cells with ASC osteogenic induction medium and use ASC growth 
medium to culture uninduced PASC cells as a negative control. Incubate PASC cell for 
21 days and gently change the medium every third day without disturbing the cell 
monolayer. 
3.2.3 Photonic Crystal Biosensor Surface Preparation  
PCs were sonicated for one minute in acetone, followed by cleaning with IPA and water. 
After thorough drying with N2, devices were oxygen-plasma treated for 1 minute to 
facilitate attachment of a liquid containment gasket. A polydimethylsiloxane (PDMS) 
gasket with an internal area of 1×1 mm
2
 was prepared with a thickness of 10 mm. After 
application of the gasket well, the PC surface was hydrated with phosphate buffered 
saline (PBS), and a layer of fibronectin was adsorbed to promote cellular attachment. The 
sensor was inserted into a custom holder attached to the motorized stage of the 
microscope, followed by PWV image scanning. 
3.2.4 Customized Stage Holder with Chamber 
A customized holder with chamber on the scanning stage of the microscope is 
built to fix the PC biosensor on the stage. The holder can avoid the random movement of 
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the PC biosensor on the stage, which may caused by pipetting liquid from or to the basket 
around the PC device and thus influence the relative imaging position. The PC device can 
be screwed onto the custom holder and then the holder can be further fixed to the 
scanning stage together with the PC. To be utilized in the dynamic live cell imaging, a 
customized chamber is built to cover the holder and can be connected with the CO2 mixer 
to provide 5% CO2 air with humidity to maintain certain pH value of the cell medium, 
which is necessary to the long term live cell survival. 
3.2.5 Development of Traction Software for Cell Boundary Evolution 
Cell movement is hardly avoidable during live cell imaging and thus there is a 
need to measure and characterize cell displacement/behavior dynamically. To this end, 
numerical methods to detect and track cells are necessary along with tools performing 
quantitative analysis. Automated and high throughput computational imaging analysis 
methods are essential for accurately analyzing the spatiotemporal cell membrane 
dynamics. Semi-automated contour-based analysis methods have been used to measure 
protrusion activity of the cell. Recently, more sophisticated algorithms have been 
developed to track the protrusive movement of the cells during adhesion or random 
migration. The level-set-based approach has been applied to reconstruct the continuous 
motion of cell membrane from video images [94, 95]. However, this approach is 
computationally demanding and it is also challenging for the whole-cell tracking with 
general cell shapes. 
In this work, we generalized this level-set-based method to whole-cell tracking, as 
well as balanced the tracking accuracy and computational cost. As such, our imaging 
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analysis tool can be utilized to detect and track whole-cell membrane movement for an 
extended period of time with reasonable computational cost. The dynamic mass 
redistribution can thereafter be quantified and correlated with the membrane protrusions. 
The overall flow chart of the software program is shown in Figure 3.1, which includes 
cell boundary detection, boundary evolution, time course quantification and cross-
correlation analysis. 
To detect the cell edge, the k-means clustering method was used to differentiate 
the different intensity layers of the PWV image. It is relatively robust to imaging noise 
and uneven background. For cell boundary evolution, we adapted the level set method 
(LSM) as described in [94, 95]. The level set method is an approach for tracking the 
evolution of complex boundaries, which is briefly described here.  
The following equation defines the location of cell boundary at a certain time: 
 
 
where Γ(t) represents the cell boundary at time t; the point (x, y) is located at the cell 
boundary; φ(x,y,t) is the level set function and it represents the signed distance from 
location (x,y) to the boundary Γ(t) at time t. Equation (3-1) illustrates that the cell 
boundary Γ(t) can be estimated at the zero level of the level set function φ(x,y,t) at any 
time t. To simplify calculation, we assume that the cell boundary moves toward its 
normal direction, and the cell boundary evolution thus can be described as a Hamilton-
Jacobi equation: 
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where V(φ(x,y,t),t) is the speed function of level set function φ(x,y,t) at time t;  
represents the gradient operator; and | • | denotes the Euclidean norm. Equation (2) 
depicts that the cell boundary Γ(T) can be propagated to its consecutive frame boundary 
Γ(T+1) using LSM through estimating the intermediate boundaries.  
In general, it is a challenge to accurately align the corresponding boundary points 
between two time frames, assuming normal propagation. This problem of misalignment 
is especially severe at the sharp corners of the boundary with large curvatures at the front 
or rear parts of cell. One possible solution is to decrease the step length of the level set 
method during boundary evolution. However, this will result in a significant increase in 
computation time.  
To balance the computational accuracy and calculation time, we use a reasonable 
small step length in the level set method to estimate enough intermediate boundaries 
between each pair of time frames. Then we apply a spline fit method to map all the 
intermediate boundaries to spline boundaries parameters by a 1D coordinate. Using this 
approach, the problem of aligning the boundary between successive frames is reduced to 
aligning 1D spline coordinates. During the boundary alignment and propagation, several 
types of boundary misalignment with geometric conflictions are checked and corrected, 
as shown in Figures 3.2. 
To map the mass redistribution and boundary protrusion along the cell edge, the 
sampling window on the PWV image is selected to be about 0.6 µm in depth and 1.25 
µm in width along the cell edge. To build the sampling band (which is average intensity 
and velocity in region located near the edge of the cell at certain depth with a certain 
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width), we use a distance map (an image which intensity is the Euclidean distance to the 
cell boundary) to acquire a constant band with 0.6 µm in depth toward the cell center 
along cell boundary. The windows are then used as masks for sampling PWV shift and 
boundary displacement at a given time and location. The sampling procedure in temporal 
dimension is done as follows: (1) For the PWV shift, the sampling window is used to 
mask the PWV shift image and calculate the average PWV shift value inside the 
sampling window; (2) The cell boundary displacement is also calculated by averaging the 
displacement vectors of boundary points at the corners of the windows. Therefore, both 
the PWV shift (along the cell boundary) and boundary velocity are sampled into a two 
dimensional map. Then the spatiotemporal relationship between mass redistribution and 
cell morphological behavior along the boundary can be studied based on the two 
dimensional map. 
To investigate the spatial-temporal relationship between PWV shift and cell 
boundary evolution at migration initiation, the cross-correlation (CC) along the temporal 
and spatial dimensions are calculated between PWV and cell boundary translocation, 
respectively. The temporal cross-correlation is defined by the following equation: 
 
 
 
where S and B represent the time courses of PWV shift and cell boundary translocation, 
respectively; τ denotes the temporal difference between two time courses S(t) and B(t); 
Cov( ) is the covariance of two time courses between PWV shift and cell boundary 
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evolution; σS and σB represent the corresponding standard deviations of the centered time 
courses. And Cov( ), σS and σB are defined as in the following equations: 
 
 
 
 
where E[ ] represents the expectation value of a random variable; Var( ) is the variance; 
µS and µB denote the means of the time courses of PWV shift and cell boundary 
translocation, respectively. Equation (3-3)-(3-4) reflect that the temporal difference τ 
between two time courses can be described as peak value of the coefficients calculated by 
the normalized cross-correlation. The global normalization with maximum correlation 
among all sampling window was used to modify the Pearson’s cross-correlation, to 
highlight the subcellular regions with significant change in mass redistribution or more 
cell protrusion. The spatial cross-correlation functions are calculated in a similar fashion 
to evaluate the spatial shift between the line scans of mass redistribution and cell 
protrusion along the whole time course of imaging.  
3.3 Results and Discussion  
3.3.1 Detection of Live Cell Attachment 
We demonstrated the detection of single stem cell attachment using PCEM 
imaging system. Murine dental stem cells (mHAT) were cultured and allowed to attach to 
a PC surface prepared with fibronectin over a period of two hours. From the series of 
peak wavelength value (PWV) images (Figure 3.3(a)) gathered at 10 minute intervals, 
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initial attachment times can be identified within the 10 minute period of image 
acquisition. Cells are observed attaching to the pretreated PC surface, with initial 
attachment characterized by small, round areas of PWV shift, consistent with spherical 
cells exiting suspension. As time progresses, average cell diameter increases, and 
membrane boundaries become more irregular as cellular processes begin to extend from 
cell bodies. Many cells maintain highest shifts at their periphery, which is consistent with 
the high concentration of cytoskeleton protein necessary for boundary maintenance and 
lamellar extension. Random locomotion is observable, which reveals that cellular 
detachment results in a full recovery of initial PWV values when a cell moves to a new 
location. As cells attach and spread, positive PWV shifts are observed due to an increase 
in the concentration of cellular material within the evanescent field region of the PC.  
Representative spectra are shown from inside, boundary and outside of the 
attached stem cell (Figure 3.3(b)), demonstrating a definitive whole-spectrum shift of the 
characteristic resonant peak. For instance, the spectra of three specific locations are 
plotted in Figure 3.3(b) as black, red and green curves, which are corresponding to the 
three small circles in Figure 3.3(a) at 30 and 50 minutes (black circle –cell center; red 
circle–near cell edge and shifted from outside of the cell boundary to inside of the cell 
boundary as cell spreading; green circle–outside of the cell boundary). At 30 minutes, the 
spectra peak of the location (red curve) is similar to that of the background pixel (green 
curve). As the cell attaching and spreading, the cell boundary crosses the location at red 
circle, thus the peak of the red curve shifted to be similar with the spectra at cell center 
(black curve). This clearly indicates that the PCEM system can detect cell attachment 
dynamically through peak resonance shift values. 
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One interesting phenomenon, as shown in Figure 3.3(a), the PWV images indicate 
that the cell falls on the surface and start to attach after a while. This earlier attaching 
time varies for individual cells and it could be ranged from 10 minutes up to 50 minutes. 
This detection ability at earlier attachment is unique in PCEM for live cell imaging. And 
it can’t be easily detectable in conventional bright-field (or fluorescence) imaging 
modalities, as demonstrated without any obvious changes at the bright-field images 
(yellow arrows in Figure 3.3(a) at 20 minutes). During this earlier attaching time, it is 
possible that the cell is probing the surrounding environment, such as pulling or pushing 
the extracellular matrix (ECM) fibers absorbed to the substrate surface for testing the 
material stiffness, surface structure and roughness, as well as selecting the binding sites. 
It is likely that the mass redistribution of the cell body will also start from this earlier 
attaching time, including the transmembrane receptors (e.g. intergrin) relocation to the 
focal adhesion sites at the bottom of the cells. Therefore, PCEM imaging system can 
successfully detect this mass redistribution procedure at the live cell earlier attachment. 
We next performed the PCEM imaging of live cell attachment for different cells 
to demonstrate the identification of the imaging system. Three different stem cells (32D, 
ASC, mHAT) were tested with the PCEM imaging. 32D cells are interleukin-3 (IL-3) 
dependent murine myeloid progenitor cells that are widely used as an in vitro model of 
hematopoiesis [96, 97]. Adipose-derived stem cells (ASC) [98, 99] and dental pulp 
epithelial stem cells (mHAT) [100, 101] are both mesenchymal cells commonly used in 
bone tissue engineering and regenerative medicine. Both PWV images and bright-field 
images are obtained and the statistical results are analyzed based on five cells in each 
type of stem cells. As shown in Figure 3.4, the three different stem cells demonstrate 
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distinct features in the PWV images, such as aspect ratios, areas, perimeters, lengths and 
widths, etc. For example, the aspect ratio of the attached cell body for ASC is significant 
higher than the other two types of stem cells (mHAT and 32D cells). While the attached 
cell areas and perimeters of 32D cell are significant smaller than ASC and mHAT cells. 
One can utilize these attachment information obtained from the PWV images to identity 
and classify different stem cells.  
Furthermore, dynamic attachment features can be extracted from the dynamic 
acquisitions using PCEM imaging system. As shown in Figure 3.5, sequences of video 
frames for PWV and bright-field images are analyzed for mHAT cells attachment and the 
dynamic changes during attaching procedures are obtained, such as attaching areas, 
perimeters, aspect ratios, centroid locations, mean PWV intensities, etc. For instance, the 
timing and gradient of the cell areas spreading and perimeters growing during attachment 
are significantly different among the three different stem cells. As shown in the Figure 
3.6, the dynamic analysis of PCEM imaging results demonstrate that the 32D cell can 
fully attach within 10~20 minutes, while the ASC and mHAT cell will spend more than 
40 minutes to be able to fully attach on the substrate surface. This phenomenon can be 
possibly explained by the highly dynamic mobility capability of the 32D cell, as it can be 
differentiated to white blood cells and share some of the mobility features with the white 
blood cells. 
3.3.2 Dynamic Detection of Single Cell Migration 
Cell migration plays essential roles in maintenance and development of multi-
cellular organisms, including embryogenesis, tissue regeneration, wound healing, and 
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cancer metastasis. For example, endothelial cells are programmed to migrate toward the 
site of nascent blood vessels during tissue regeneration and angiogenesis which supply 
nutrients for the maintenance and growth of surrounding tissues. During wound healing 
procedure, stem cells migrate toward the wound place and differentiate into specific cell 
types. Therefore, understanding the underlying mechanisms regulating cell migration has 
important implications in regenerative medicine and stem cell therapeutics. 
The PCEM imaging system can dynamically detect cell migration. As shown in 
Figure 3.3(a), a sequence of PWV images represents the migration of mHAT cells in 
random directions after attached to the substrate surface. The intensity change of the 
PWV images indicates the mass redistribution of the cell body during migration 
procedure. To investigate the spatiotemporal partition of mass redistribution at the cell 
boundary of the migrating cells, photonic crystal biosensor-based live cell imaging and 
image analysis methods are integrated to visualize and quantitatively analyze the cell 
migration. The image analysis method, as described in methods section, is developed to 
automatically analyze the dynamic movement of the boundary evolution during cell 
migration.  
The temporal cell boundary traction results from a single migrating mHAT cell 
are shown in Figure 3.7 and the color (from blue to red) represents the cell boundary 
evolution time (from 0 to 220 minutes). The resulting temporal-spatial boundary 
evolution map is shown in Figure 3.8, while the x-axis indicates the temporal sample 
points along boundary evolution time (in units of minutes) and y-axis indicates the spatial 
sample points along the normalized cell boundary length (in absence of units). The color 
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change of the evolution map indicates the cell boundary evolution cumulative distance (in 
unit of um) at each temporal-spatial sample point, while blue represents short migration 
distance and red represents long migration distance. From the boundary evolution map, 
we can see that the mHAT cell is mainly attaching and spreading during first ~50 
minutes, so the boundary movement distance is relatively short (lower than 5 um) as the 
blue color indicating in the evolution map. Then, the mHAT cell starts to migrate towards 
“East” direction after ~70 minutes, so the boundary movement distance starts to 
directionally increase and reaches the longest migration distance (around 14 um) after 
120 minutes. Two representative cross-section curves along temporal direction are shown 
in Figure 3.9, while the blue curve represents the point A and red curve represent point B 
at the cell boundary in Figure 3.7. The two curve starts with similar migration distance 
for the first 50 minutes during attachment, then the red curve raises much higher (around 
three times higher) and reaches a plateau value (around 14 um) after 120 minutes.  As we 
can see from Figure 3.7, point A corresponds to the protrusion part of leading frontier in 
the cell body during migration and it can be explained well that the leading frontier has 
the longest migration distance. Our future work is to uncover the underlying mass 
redistribution mechanism during cell migration using the PCEM imaging system 
combined with the automatic analysis software. 
3.3.3 Detection of Stem Cell Differentiation 
Stem cell can differentiate into special types of cells and maintains the normal 
multi-cellular organism development, such as in tissue repair or embryonic development. 
Due to modified gene expression, many characters of a stem cell body can have 
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significant changes during differentiation, including shape, size, metabolic activity and 
responsiveness to certain environment signals, etc. Different types of stem cells can have 
very distinct features among those physical changes during differentiation. By detecting 
those physical changes, one can distinguish whether the stem cell is differentiated or 
characterize the differentiation stage.   
We performed the adipose stem cell (ASC) osteogenic-differentiation assay on 
photonic crystal biosensor surface and measured the peak resonance wavelength change 
using PCEM imaging system. The ASCs were treated with the osteogenic induction 
medium for entire differentiation time. Every other day, the treated ASCs were collected 
and then seeded on the photonic crystal biosensor surface upon imaging time to measure 
their attachment performances. The resulting sequence of detected differentiation images 
are shown in Figure 3.10. From both the bright-field and PWV images, we can clearly see 
that the ASC is more elongated with a thin spindle shape at day 0 of differentiation 
procedure. As the differentiation carrying on (e.g. day 4), the shape of the ASC gradually 
becomes to be more rectangular, which is progressive to the morphology of osteoblasts. 
At day 10, the induced osteoblasts demonstrate a rectangular morphology, which is 
similar to an adult osteoblast’s morphology. These imaging results illustrate that the 
PCEM imaging system can successfully detect the attachment performance change 
during stem cell differentiation procedure. The future work includes applying this PCEM 
detection assay to different types of stem cell differentiation, such as 32D stem cell 
differentiation. 
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3.4 Figures 
 
 
 
 
Figure 3.1  The flow chart of the software program includes cell boundary detection, 
boundary evolution, time course quantification and cross-correlation analysis.   
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Figure 3.2  Special cases of boundary misalignment with geometric conflictions 
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Figure 3.3  Label-free, Dynamic Detection of Stem Cells Attachment using PCEM. (a) 
Stem Cells (mHAT) were seeded on a fibronectin-coated PC sensor surface and start to 
attach after 10 minutes (Top row: PWV images, bottom row: bright-field images), 
indicating a higher localization of cellular material at the sensor surface which can be 
expected during cell spreading. (b) Spectra are shown from inside, boundary and outside 
of the attached cell at 30 and 50 mins (3 regions are marked with black, red and green 
circles). 
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Figure 3.4  Label-free Detection of Stem Cells Attachment using PCEM. (a) The three 
different stem cells (32D, ASC, and mHAT) demonstrate distinct features in the PWV 
images, such as (b) aspect ratios or (c) attached areas of the cell bodies. 
(a) 
(b) 
(c) 
32D               ASC               mHAT 
32D                ASC               mHAT 
32D                         ASC                    mHAT 
 51 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5  Dynamic changes during mHAT cells attaching procedures are obtained with 
PCEM and analyzed with the boundary evolution software. Cell information, including 
(a) attaching areas, (b) perimeters, (c) aspect ratios, (d) length, (e) width, (f) centroid 
locations,(g)min image intensities, (h) max image intensities, (i) mean image intensities, 
are plotted in temporal dimension. 
 
Cell Area Cell Perimeter Cell Aspect Ratio 
Cell Length Cell Width Cell Center Location 
Cell Min Intensity Cell Max Intensity Cell Mean Intensity 
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Figure 3.6  Comparison of dynamic of PCEM imaging results analysis (including 
temporal changes of  cell area, aspect ratio and mean intensity) for three different stem 
cells (32D, ASC, and mHAT). 
(a) 
(b) 
(c) 
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Figure 3.7  Stem cell boundary evolution extracted from PWV images along temporal 
dimension (color bar demonstrates the time for cell attaching and spreading). 
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Figure 3.8  Two-dimensional map represents the spatiotemporal relationship between 
mass redistribution and cell morphological behavior along the boundary.  
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Figure 3.9  Representative cross-section curve for cell boundary evolution along (a) 
temporal dimension and (b) spatial dimension. 
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Figure 3.10  The PCEM detected  PWV and bright-field images for ASC Osteogenesis 
differentiation at different stages (day 0, day 4 and day 10).  
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CHAPTER 4 
LABEL-FREE IMAGING OF NANOPARTICLE ATTACHMENT ON 
PHOTONIC CRYSTAL BIOSENSOR 
 
4.1 Background and Motivation  
Nanoparticles (NP) prepared from dielectric [102], semiconductor [103], metal 
[104], and magnetic [105] materials have recently become important elements of 
biosensor technology due to the ability to prepare their surfaces with ligands that enable 
them to recognize specific target molecules, and their ability to interact with 
electromagnetic fields in useful ways [106-116].  For example, nanoparticles with 
dielectric permittivity greater than that of water may be used as secondary tags for 
enhancing the signals from resonant optical biosensors [117], while magnetic 
nanoparticles are used to facilitate particle manipulation while at the same time providing 
a mass amplification tag for acoustic biosensors [118].  Likewise, metallic nanoparticles, 
comprised of silver or gold, couple with external illumination sources to generate surface 
plasmons, which are used to enhance local electric fields on the nanoparticle surface 
[119, 120].  
While many biosensing approaches are capable of sensing the adsorption of large 
numbers of nanoparticles [121], several approaches are capable of detecting the presence 
of a single nanoparticle, if the particle is adsorbed to a specific active location [122-126].  
Due to the difficulty of directing analytes to precise locations on a substrate surface 
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where a biosensor has sensitivity, one approach to overcoming this limitation is to utilize 
a biosensor surface in which the entire surface area is active as a sensor.  Through the use 
of an imaging detection approach, the adsorption of analyte upon any region within the 
field of view may be measured.  Imaging-based biodetection utilizing optical sensors has 
been demonstrated using surface plasmon resonance [127-129], photonic crystal 
biosensors [67-70, 130], and dielectric thin film interference sensors [131-134].  Such 
approaches are advantageous because analytes that produce highly localized changes in 
dielectric permittivity, such as cells, virus particles, or nanoparticles, may be detected, 
with the potential to observe the attachment of individual targets.   
In this work, we apply the photonic crystal enhanced microscopy (PCEM) to 
detect the attachment of dielectric and metallic nanoparticles upon a photonic crystal 
(PC) surface.  While our initial demonstration of PCEM described imaging the spatial 
distribution and time evolution of live cell attachment strength to a functionalized PC 
surface with 0.6 µm pixel resolution [66], here we report the detection of nanoparticles 
that are smaller than the pixel size. We demonstrate that metallic (gold) nanoparticles or 
nanorods produce highly localized effects upon the photonic crystal (PC) resonant 
reflection spectrum that enable individually attached particles (as small as ~65 nm×30 
nm) to be easily observed by two distinct mechanisms. Furthermore, we observe that the 
dielectric permittivity of particles results in a local shift in the resonant wavelength of the 
PC, while the optical absorption of nanoparticles results in a localized reduction in the 
resonant reflectivity magnitude. We anticipate the use of dielectric or metallic 
nanoparticles as functionalized tags in “sandwich” style assays that can be used to 
visualize the presence of individual captured analyte biomolecules upon a PC surface.  
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4.2 Material and Methods 
4.2.1 FDTD Simulation 
Simulation of the reflection spectrum and the electric-field distributions with 
FDTD is performed to predict the peak resonance wavelength and intensity shift caused 
by the nanoparticle attachment. Two periods of the PC are simulated with the periodic 
boundary conditions applied to perpendicular to the grating structures. The incident light 
is set to be p-polarized (TM mode) from normal direction beneath the PC device. The 
nanoparticle is placed in several different positions on the PC surface, including on the 
top of the grating structures and between the gap of the grating structures.  
4.2.2 Photonic Crystal Biosensor Surface Preparation 
PC surface were prepared similar to the previous chapter, except no need for 
coating an extracellular matrix molecules. Briefly, PCs were cleaned with isopropyl 
alcohol (IPA) and MilliQ water, respectively. After thorough drying with Nitrogen air 
(N2), the PC biosensors were treated with oxygen-plasma and attached with a PDMS 
gasket. Then the sensor was inserted into a custom holder attached to the motorized stage 
of the microscope, followed by PWV image scanning. 
4.2.3 Deposit Patterns of Polymer Spots Using tDPN 
An array of nano-patterns is deposit on the photonic crystal surface with a newly 
developed technique - thermal Dip-Pen Nanolithography (tDPN) [135-138]. A heated 
AFM tip deposited polystyrene nanopatterns on the photonic crystal surface. This process 
consists of two major steps. The first step is to ink the AFM tip. A custom-built AFM tip 
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made of doped silicon was heated up to 260ºC by applying electric currents through the 
AFM tip. As the AFM tip was heated, we brought the AFM tip into contact with a 
polystyrene (PS) fiber using a micromanipulator under a microscope. Once the tip 
contacted the PS fiber, the PS melted and inked the heated AFM tip. The second step is to 
deposit PS onto the photonic crystal surface. The inked heated AFM tip was mounted on 
an AFM (Model MFP-3D, Asylum Inc.) and scanned across the photonic crystal surface. 
When the AFM tip was heated up and reached a temperature of 260ºC, the molten PS 
migrated from the heated AFM tip to the photonic crystal surface, formed solid PS 
nanopatterns upon cooling by the photonic crystal surface. For fabricating nanolines of 
PS, the AFM tip scanned the PC sample at a velocity of 150 nm/s. For fabricating 
nanodots of PS, the AFM tip dwelled on the PC sample for several seconds while 
heating, then heat was turned off, finally the AFM tip withdrew from the PC sample. 
4.2.4 Nanoparticle Automatic Counting 
After acquiring the PIV images from the PCEM imaging system, accurately 
counting the number of nanoparticles in each microspot is essential to the final detection 
results, but also can also be a tedious procedure due to the large number of nanoparticles 
in each field of view (it typically reaches several hundreds, even up to thousands). In this 
study, we developed a software to analyze the PIV images and automatically count the 
nanoparticles. The imaging analysis procedure is shown in a flow chart in Figure 4.1 and 
can be summarized as follows: (1) Image preprocessing to remove the noise and non-
even background; (2) Image segmentation to detect local maxima; (3) Ad hoc region 
characterization to eliminate the false-positives.  This sub-section will introduce some of 
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the imaging algorithm involved in this program along with the development of this 
counting software. 
1. Preprocessing 
The analysis software begins with a preprocessing procedure, which can be 
decomposed into two major components: (1) denoising with a low-pass filter; (2) uneven 
background removal.  
Noise can be introduced to the imaging system during the image acquisition 
procedure which influences the determination of the resonance wavelength shift and 
intensity change. For denoising procedure, a Wiener filter is applied to filter out the noise 
by estimating the noise variance from local neighborhood. The Wiener filter is based on 
the prior knowledge of the spectral properties of the original stationary signal and noise 
spectra assumed to be known (more precisely, the spectral properties are estimated from 
the image itself using local neighborhoods). A minimum mean-square error (MMSE) is 
used as the performance criterion in the filter design procedure which can benefit to the 
capability of controlling the output error to the image. Therefore, the Wiener filter can 
avoid the problem of singularity of the typical inverse filtering and can be designed 
straightforwardly. The neighborhood used has size 3-by-3, and an example phantom 
image with noise and the resulting filtered image are shown in Figure 4.2. 
The non-uniform illumination background is another typical disruption to the 
image processing procedure, which is often difficult to remove completely.  To estimate 
the uneven background, a morphological opening of the image is performed, as shown in 
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the Figure 4.3(a).  Then by subtracting the estimated background image from the 
denoised image, the resulting image demonstrates a relative uniform background, as 
shown in Figure 4.3(b). 
2. Extended Maximum Detection 
The extended maxima transform is a morphological operation aiming at finding 
local maxima in grayscale images.  It is defined as the result of the regional maxima 
operation applied on the H-maxima transform of the grayscale image.  The H-maxima 
transform (where H is a non-negative scalar) locates peaks of height larger or equal to H.  
In particular, this discards low contrast peaks which are more likely the result of noise in 
the grayscale image.  The regional maxima operation then segments the grayscale image 
into regions corresponding to the different peaks (i.e. local maxima) in the image. In the 
context of nanoparticle counting, this operation selects candidate regions that may 
correspond to nanoparticles.  Further refinement will discard candidates based on region 
properties. The resulting segmented mask image is shown in the Figure 4.4(a). 
3. Connected Components Analysis 
To label and count each nanoparticle, connected components analysis (CCA) is 
applied to the segmented mask image. The CCA algorithm can label each object in the 
image and count it as one element, and then return a matrix with all of the labeled 
elements. Such labeling is useful, not only for counting the nanoparticles but to process 
them individually (by characterizing their shape and eliminating false positives as 
described in the next section).  The CCA algorithm can be summarized by the following 
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steps: (1) A run-length encode (RLE) algorithm, often used in the data compression, is 
applied to the segmented mask image to obtain and store the sequences of the connected 
pixels with the same intensity values. (2) Next, all of the sequences are scanned to assign 
a preliminary label and record the label equivalence to each of them. (3) After the scan is 
finished, the equivalence classes are resolved to group the elements to one another. (4) 
Based on the results from resolving equivalence classes, the elements are relabeled and 
recounted to obtain the correct sequence number. 
4. Ad hoc Nanoparticle Candidate Region Characterization 
We next applied an ad hoc characterization to eliminate the false positive count, 
which can possibly come from noise, artifacts or segmentation inaccuracies. This step 
consists in measure shaping properties on each labeled region, and using empirical rules 
to eliminate undesirable candidates. The rules enforced are: (1) the total area of the 
nanoparticle region must not exceed a certain threshold, (2) the region must not be too 
elongated (this is measured by the long-axis to short-axis lengths ratio) and (3) the region 
must not extend too much in the y-direction.  The last rule stems from the fact that 
images are degraded by stripes in the y-direction, which typically generates some false 
positives along the stripes. The resulting segmented mask after removal of undesirable 
candidates is shown in Figure 4.4(b). 
5. Recount  
After removing the effect from artifacts, we finally count to the nanoparticles in 
the resulting image. For validation, the automatic counting procedure was compared to 
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the numbers obtained by manual counting for a few datasets. Counting results are shown 
on Table 4.1 and confirm that the automatic counting algorithm provides an accurate 
estimate of the true count. The counting results on the phantom image of nanoparticles 
are shown in Figure 4.4(c), while the number of the small black circles represents that of 
nanoparticles. 
4.3 Results 
4.3.1 FDTD Simulation Results 
The simulated electric-field power distributions (|E|
2
) of the PC at the resonant 
wavelength with/without a TiO2 (500 nm) and Au (100 nm) nanoparticle are shown in 
Figure 4.5, in which a uniform plane wave illuminates the structure at normal incidence 
with a magnitude of E = 1 V/m.  The “Empty” PC simulation (Figure 4.5(a)) 
demonstrates the expected establishment of an evanescent electric field at the surface 
with enhanced electric field magnitude that develops due to the formation of electric field 
standing waves.  Figure 4.5(b-e) demonstrate the presence of TiO2 or Au nanoparticles at 
two slightly different locations on the PC biosensor surface (deposited on top of a grating 
tooth, or at the bottom of the gap between teeth), respectively.  The presence of 
nanoparticles (at the bottom of gap between teeth) induces substantial changes in near-
field distributions and results in a shift of resonance wavelength by Δλ = 1.04 nm (TiO2) 
and Δλ = 0.14 nm (Au).  The predicted reduction in the resonant intensity by the presence 
of the TiO2 and Au nanoparticles is ΔI = 60% and ΔI = 13%, respectively (Figure 4.6). 
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4.3.2 Dielectric Nanoparticle Detection 
To facilitate investigation of PCEM’s ability to detect individual nanoparticles 
with tightly controlled spatial distribution and size, we first sought to intentionally 
deposit patterns of polymer spots using tDPN.  The principle of tDPN is to use a heated 
AFM tip to deposit polystyrene (PS) nano-patterns on the PC surface.  We printed 3×3 
arrays of PS dots (540 nm diameter, 40 nm height, and 5 µm gaps between dots) on a PC 
surface confirmed by AFM imaging (Figure 4.7).  Figure 4.8 displays the measured PWV 
images of the tDPN printed nano-dots.  From the spectrum of two neighboring pixels 
(marked with black and green circles in Figure 4.8 inset image), we can visualize a peak-
wavelength shift of Δλ = 0.5 nm caused by the nano-dots (black line), compared to the 
background pixel (green line) (Figure 4.9).  The PCEM-measured diameter (Figure 
4.10(a)) closely matches the AFM-measured diameter (Figure 4.10(b)), except that the 
nano-dot dielectric permittivity slightly increases the PWV of surrounding pixels.  It is 
important to note that the nano-dots are approximately the same size as the pixel, so a 
single nano-dot can partially occupy several adjacent pixels at the same time.  
Having demonstrated the ability to observe and resolve dielectric-based polymer 
nanoparticles that were intentionally patterned on the PC, we next sought to detect 
dielectric TiO2 nanoparticles of approximately the same size, but distributed randomly on 
the PC surface (Figure 4.11).  The PC surface was prepared by cleaning with isopropanol 
and deionized (DI) water, followed by drying using N2.  To further facilitate nanoparticle 
attachment, the PC was oxygen-plasma treated for five minutes after cleaning.  The TiO2 
nanoparticle is 500 nm in diameter (Microspheres-nanospheres, #220374-10) and 
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incubated in DI water on the PC surface for two hours and then imaged via PCEM.  
Figure 4.12 shows the measured PCEM spectra for two neighboring pixels (black line 
represents the location of an adsorbed TiO2 nanoparticle, while the green line represents 
a background pixel without an adsorbed nanoparticle).  The TiO2 nanoparticle induces a 
highly localized and easily observed peak-wavelength shift of Δλ = 1.12 nm and a peak-
intensity reduction of ΔI = 58%.  Calculating these values for each pixel in the field of 
view allows us to form the PWV (Figure 4.11(a)) and PIV (Figure 4.11(b)) images for 
several independently adsorbed TiO2 nanoparticles.   
4.3.3 Metal Nanoparticle Detection 
We next sought to detect the presence of surface-adsorbed gold (Au) 
nanoparticles of approximately 100 nm diameter (Sigma, #742031-25ML), distributed 
randomly on the PC surface.  The PC surface was prepared as described above.  Scanning 
electron microscopy (SEM) images of single gold nanoparticles on the PC surface are 
shown in Figure 4.13, demonstrating that the particles are present as distinct individuals, 
rather than as clusters.  Individual Au nanoparticles were observed to cause a pronounced 
change in the resonant reflection spectrum for only the pixels of the PCEM image where 
the particle was adsorbed.  We observe a shift in the peak reflected wavelength of Δλ = 
0.15 nm, and a reduction in the peak reflectance intensity of ΔI = 12%.  The PWV shift 
(Figure 4.14(a)) is a result of the increased real part of the dielectric permittivity of gold 
with respect to the surrounding water medium, while the decrease in PIV (Figure 4.14(b)) 
is caused by the imaginary part of the refractive index of gold at the resonant wavelength 
of the PC, which results in highly localized optical absorption.  The localized nature of 
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the effect can be observed by comparing spectra from neighboring pixels (black line 
represents a pixel from the location of an adsorbed Au nanoparticle, while the green line 
represents the background region without an Au particle), as shown in Figure 4.15.   
4.4 Discussion 
 The PCEM detection instrument configuration with 10× objective lens described 
in this work provides a field of view of 300×300 µm
2
, comprised of an array of 0.6×0.6 
µm2 pixels, determined by the combined effects of the objective numerical aperture, the 
scan increment and the pixel size of the CCD camera within the imaging spectrometer.  
The resolution with which individual nanoparticles may be identified as distinct objects is 
partially determined by the above instrument parameters, but is also influenced by the 
ability of the PC surface to confine the lateral propagation of its resonant electromagnetic 
field standing wave.  Ultimately, the resolution of our approach will not be capable of 
exceeding the diffraction limit, which for a wavelength of λ = 620 nm and our numerical 
aperture of 0.25, is d = 1518 nm.  The resolution of the optical system can be calculated 
using Abbe’s formula   
d= (0.612∙λ)/(n ∙sinα ),                                           (4-1)  
where λ is the wavelength of the imaging radiation; n is the medium refraction index 
between the light source and the lens; α denotes half of the angular aperture of the light 
source.  The n∙sinα term in Abbe’s formula represents the numerical aperture (N.A.).  
Using the PCEM images of individual nanoparticles that are smaller than the pixel 
size, we are able to characterize the extent to which a nanoparticle can influence the 
resonant properties of neighboring pixels, by observing how the resonant reflectance 
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properties are influenced as one moves laterally across the PC surface.  Because the 
location of a nanoparticle within a pixel of a PCEM image is random, it is important to 
note that a particle will always be within a diffraction limited distance of up to five 
adjacent pixels, and thus we would not expect to observe a single pixel with a shift in 
wavelength or reflected intensity.  The distribution of PWV and PIV shift in the 
horizontal and vertical directions surrounding individual TiO2 nanoparticles in our 
images are plotted in Figure 4.16.  The data reveals that a 500 nm diameter surface-
adsorbed TiO2 nanoparticle results in a positive shift in PWV that extends approximately 
6 µm in the horizontal direction (perpendicular to the PC grating lines) and 5 µm in the 
vertical direction (parallel to the PC grating lines).  Calculating the full-width at half-
maximum (FWHM) of the point spread function of ten separate TiO2 nanoparticles 
results in a mean FWHM = 1.56 µm, and a standard deviation of 0.26 µm in the 
horizontal direction and FWHM = 1.20±0.28 µm in the vertical direction.  Thus, for two 
neighboring nanoparticles to be observed independently, they must be separated by at 
least 2∙FWHM, approximately 3.2 µm.  Interestingly, PIV-based PCEM images of the 
same TiO2 nanoparticles measured using the reduction in reflection efficiency results in 
slightly improved resolution.  We measured FWHM of 0.95±0.09 µm for PIV images in 
the horizontal direction, and FWHM of 0.96±0.39 µm in the vertical direction.  Results 
are summarized in Table 4.2.   
Similar results are obtained when observing the point spread function of surface-
adsorbed 100 nm Au nanoparticles.  Observation of the variation in PWV and PIV in the 
horizontal and vertical directions surrounding an individual Au nanoparticle, plotted in 
Figure 4.17, results in a FWHM of 1.15±0.05 µm for PIV images in the horizontal 
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direction, and FWHM of 0.97±0.07 µm in the vertical direction.  We observe that 
surface-adsorbed dielectric and metallic nanoparticles extend their influence to 
surrounding regions of the PC surface for approximately the same distance.  
Our observations of the resolution of PCEM images of isolated nanoparticles (100 
nm Au NP) suggest that the resonant electric field standing waves of any particular 
region of the PC are influenced by surrounding regions that are ~3 µm away.  
Fundamentally, this distance is determined by the design of the PC, as discussed in 
previous work [65].  The periodic grating structure results in partial back-reflection of 
resonantly coupled light that has its propagation vector oriented parallel to the PC 
surface.  The modulation of the grating, determined by the grating step height, the 
thickness of the TiO2, and the refractive index contrast of the TiO2/polymer/water 
interfaces, determines the efficiency with which laterally-directed light is folded back 
onto itself.  Because the FWHM is ~1200 nm, and the grating period is 400 nm, we 
estimate that ~6 back reflections are required to confine resonantly coupled light for the 
PC design used in this work.  This factor, rather than the diffraction limit, provides the 
current resolution limitation of our approach.  We have previously shown that PC 
structures with lower quality (Q) factor (broader resonant bandwidth) provide greater 
lateral confinement, so this may be a direction for future investigation.  
A point of interest for detection of metallic nanoparticles is the overlap between 
the PC resonant wavelength and the resonant optical absorption spectra of the 
nanoparticle.  In this work, no effort was directed towards aligning these two values, 
except the last experiment using AuNR.  Previous reports [139] demonstrate that Au 
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nanoparticles of ~100 nm diameter have a broad absorption spectrum with a maximum of 
572 nm, that extends to 700 nm.  Thus, the PIV images are a result of quenching of the 
PC resonance due to absorption of light by the Au, but the absorption process used to 
obtain our PIV images is extremely inefficient.  Despite this inefficiency, a single 100 nm 
Au nanoparticle provides easily measured resonant intensity contrast of ~10%.  While the 
contrast is expected to be further improved either by choosing nanoparticles with 
resonant absorption spectra that overlaps the resonant spectrum of the PC, or by 
designing a PC to more closely match the absorption of the nanoparticles.  Chapter 5 will 
address this problem by applying the AuNR with approximately the same resonance 
wavelength with the PC surface. 
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4.5 Tables 
 
 
Table 4.1  The Counting Results of Automatic Nanoparticle Counting Software. 
The automatic counting results was compared to the numbers obtained by 
manual counting for four regions of interest (ROI).   
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Table 4.2  Measured FWHM (mean ± std, in units of µm) in horizontal and 
vertical directions (in both PWV and PIV images) for 500 nm TiO2 NP and 100 
nm Au NP.   
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4.6 Figures 
 
 
 
Figure 4.1  The flow chart of automatic analysis and counting for nanoparticle (NP) 
detection using PCEM system. 
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Figure 4.2  The (a) original noisy and (b) filtered phantom images for automatic 
nanoparticle imaging analysis. 
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Figure 4.3  The results of removing  the non-uniform background in the  nanoparticle 
automatic counting algorithm. 
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Figure 4.4  The image segmentation and counting for nanoparticle (NP) detection using 
PCEM system. 
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Figure 4.5  Computer simulations of reflection and near field distributions of PC without 
and with nanoparticles (NP). The simulations demonstrate the Finite-difference time-
domain (FDTD) computed electric-field power distributions (in units of V2/m2) for 
different conditions: (a) Empty PC; (b-c) 500 nm TiO2 NP and (d-e)100 nm Au NP at 
two slightly different locations on a PC surface (deposited on top of a grating tooth, 
denoted by “Top”, or at the bottom of the gap between teeth, denoted by “Gap”). 
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Figure 4.6  FDTD-computed reflection spectra of NPs on PC surface, predicting a clearly 
measurable change in reflectance wavelength and intensity with/without nanoparticles. 
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Figure 4.7  PCEM detection of nano-dots printed with thermal Dip-Pen Nanolithography 
(tDPN).  (a) Atomic Force Microscopy (AFM) images of tDPN printed 3x3 arrays of 
nano-dots. (b) Zoomed in AFM images of one tDPN nano-dots in dimension of 
540x540x40 nm
3
. 
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Figure 4.8  PCEM reflected PWV image of the tDPN nano-dots displayed in 3D surface 
plot within a 20x20 µm
2
 field of view.  Inset: 2D PWV image, demonstrating the ability 
of PCEM to resolve PWV differences in single nano-dots attachment on PC surface.   
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Figure 4.9  Normalized spectrum of a representative tDPN nano-dot (black line) and a 
background pixel (green line).  Inset: Zoomed in image of the spectrum with 2D 
polynomial fitting (tDPN nano-dots fitting in red line, background fitting in blue line), 
indicating a PWV shift of Δλ = 0.5 nm. 
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Figure 4.10  Comparison of FWHM of tDPN nano-dots on the PC surface measured by 
AFM and PCEM. (a) tDPN nano-dots measured by AFM, indicating a FWHM (mean) of 
540 nm.  (b) tDPN nano-dots measured by PCEM, indicating a FWHM (mean) of 1.20 
µm in horizontal direction and 1.13 µm in vertical direction (measured from PWV 
image). 
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Figure 4.11  PCEM detection of randomly distributed TiO2 nanoparticles (NP). (a) 
PCEM detected PWV image of the TiO2 NP displayed in 3D surface plot.  Inset: 2D 
PWV image in gray scale.  (b) PCEM detected PIV image of the TiO2 NP displayed in 
3D surface plot (inversed for comparison).  Inset: 2D PIV image in gray scale. 
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Figure 4.12  Normalized spectrum of a 500 nm TiO2 NP and a background pixel.  Inset: 
Zoomed in image of the normalized spectrum with 2D polynomial fitting (TiO2 NP 
fitting in red line, background fitting in blue line), indicating a PWV shift of Δλ = 1.12 
nm and a PIV reduction of ΔI = 58% when the NP is present. 
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Figure 4.13  Scanning electron micrograph (SEM) of the 100 nm Au NP on PC surface. 
Inset: Zoomed in image. 
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Figure 4.14   PCEM detected (a) PWV and (b) PIV images of the Au NP displayed in 2D 
with gray scale.   
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Figure 4.15  Normalized spectrum of a 100 nm Au NP and a background pixel.  Inset:  
Zoomed in image of the normalized spectrum with 2D polynomial fitting (Au NP fitting 
in red line, background fitting in blue line), indicating a PWV shift of Δλ = 0.15 nm and a 
PIV reduction of ΔI = 12% when the NP is present. 
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Figure 4.16  Comparison of FWHM (in horizontal and vertical directions) in PWV and 
PIV images detected by PCEM with randomly distributed TiO2 nanoparticles on the PC 
surface.  FWHM (mean) in PWV and PIV images of 500 nm TiO2 NP measured by 
PCEM in (a) horizontal and (b) vertical directions.  
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Figure 4.17  Comparison of FWHM (in horizontal and vertical directions) in PWV and 
PIV images detected by PCEM with randomly distributed Au nanoparticles on the PC 
surface. FWHM (mean) in PWV and PIV images of 100 nm Au NP measured by PCEM 
in (c) horizontal and (d) vertical directions. 
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CHAPTER 5 
PROTEIN-PROTEIN BINDING DETECTION USING PCEM 
 
5.1 Background and Motivation 
Technologies to recognize the signatures of the cancer biomarkers exist for earlier 
cancer detection, diagnosis and pharmacological treatment, such as enzyme-linked 
immunosorbent assay (ELISA) [140, 141] and mass spectrometry [142]. ELISA serves as 
one of the important modalities for protein detection. It is based on the principle of 
antibody-antigen binding to recognize the target molecule and then apply fluorescence 
dye tag to enhance the signal. However, some restrictions exist with ELISA, such as 
detection limitations in terms of reliability and accuracy in earlier cancer detection which 
are mainly due to the insufficient sensitivity of the assay or the insufficient dynamic 
range needed in the low concentration of cancer biomarker detection. Conventional 
ELISA may detect concentration as low as several pg/mL for some protein biomarkers 
[143-147], but the procedure is rather complicated and may require extensive technical 
training. And thus it is challenging to implement it in point-of-care applications [148]. 
Besides, a conventional ELISA analysis typically needs more than 50 µl of blood serum, 
requires an expensive non-automated fluorescence detection instrument, and provides 
limited multiplexing capability. 
Label-free methods, including surface plasmon resonance (SPR), impedance 
imaging, interference microscopy, phase imaging with microscopy, and photonic crystal 
biosensors, etc., have also been employed to detect cancer biomarkers in the past 
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decades. Those sensing or imaging modalities have been used for their capability of 
detecting or characterizing proteins in the absence of markers or fluorophore dyes. The 
major concept of label-free imaging methods is the use of a special transducer to capture 
and convert a bio-analyte’s physical change into a measurable optical or electrical signal, 
such as a resonance wavelength shift or an electrical impedance variation. Each imaging 
technology has a distinct physical mechanism, and thus leads to its specific capabilities 
and limitations. For example, the surface plasmon resonance imaging (SPRi) is an optical 
detection method which usually use a prism coated with a thin metal (typically gold) 
layer and thus it utilizes the plasmon surface polariton fields as the illumination source 
instead of normal light [129]. When the incident light meet with the resonance 
conditions, such as certain wavelength, polarization and incident angle, the free electrons 
at the metal-dielectric interface will absorb the incident light photons and convert them 
into surface plasmon waves. Such electromagnetic modes can travel along the metal-
dielectric interface as a bound, non-radiative surface wave, which has a pronounced 
dispersion. Its field intensity is concentrated and strongly enhanced at the interface. 
Those properties make SPRi sensitive to small perturbations at the metal surface which 
are caused by the interactions between target molecules and the probe antibodies [149]. 
However, low spectral resolution and long lateral propagation of SPRi hinders its 
usefulness for applications requiring high resolution, while photonic crystal biosensor 
imaging is a promising alternative for such applications.  
Nanomedicine, namely applying nanotechnologies to medicine, is another 
emerging field which may offer new technologies to detect cancer biomarkers in earlier 
cancer development. Nanoparticles (NP) have great potential as biosensing tags for 
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protein-protein binding detection due to their nanometer scale size (comparable to 
biological molecules or antibodies), especially for gold nanoparticle (AuNP) with the 
amenability of synthesis and functionalization, less toxicity and absence of 
photobleaching.  
In this work, we apply the PCEM system to detect the protein-protein binding 
upon a biosensor surface. Our ultimate goal is to apply individual nanoparticles as 
functionalized tags in “sandwich” style assays, which can be used to detect the presence 
of captured analyte attached on a PC biosensor surface (Figure 5.1). By matching the 
plasmon resonant frequency of the gold nanorods (AuNR) to the PC resonance 
substantially increases sensitivity of this biosensing approach. NP-PCEM imaging offers 
an attractive alternative to detection using fluorescent nanoparticles, as NP-PCEM 
requires only low power broadband illumination, does not suffer from photobleaching, 
can provide long-term time-course data, and can be utilized for any type of nanoparticle 
tags. 
5.2 Materials and Methods 
Detection of protein-protein binding, which utilizes the photonic crystal surface as 
the biosensor and the gold nanoparticle as sensing tags, is performed in this work. The 
merit of this method is to take the advantages of the high sensitivity of the photonic 
crystal biosensor and the capability of single nanoparticle imaging resolution of the 
PCEM imaging system. Moreover, metal nanoparticles, including gold nanoparticles 
(AuNP), scatter light intensely near their surface plasmon resonance (SPR) wavelength. 
The localized surface plasmon resonance (LSPR) wavelength of a gold nanoparticle can 
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be tuned by many factors, such as its size, aspect ratio, coating shell thickness. Hence, the 
LSPR wavelength of a gold nanoparticle can be conveniently tuned (see section 5.3 for 
more details) to match with the photonic crystal biosensor resonance to further enhance 
the imaging contrast. 
As shown in Figure 5.2, the proposed protein-protein binding method using (NP-
PCEM) can be summarized into the following steps: (1) The probe protein (e.g. Anti-
IgG) is immobilized on the photonic crystal biosensor surface. (2) The target protein (e.g. 
IgG), which is tagged with the gold nanoparticles, is applied on the biosensor surface and 
will be captured by the probe protein. To tag the target protein, we use a flexible linker 
(e.g. SH-PEG) to link between the gold nanoparticle and the target protein. (3) After 
certain time of incubation of the tagged target protein with the immobilized capture 
protein, the unbound target protein is rinsed off and the remaining nanoparticles can be 
countable for protein-protein events. So the resulting photonic crystal biosensor surface is 
imaged with the PCEM system to measure the resonance wavelength shift and intensity 
variation. 
5.2.1 Tuning the LSPR of Nanoparticle to Match the PC resonance 
The detection efficiency will be improved if we can match the resonance 
wavelength of the PC biosensor with the localized surface plasmon resonance (LSPR) of 
the gold nanoparticle. To tune the LSPR of the nanoparticle, we can adjust its physical 
properties and consequently the electric-magnetic properties during the nanoparticle 
synthesis procedure. In this section, we introduce the Mie-Gans theory [150], which 
describes the relationship between the physical properties and the electric-magnetic 
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outcome of a non-spherical nanoparticle, to guide the gold nanoparticle synthesis 
procedure. 
The optical extinction spectrum of a prolate metal spheroid (e.g. nanorod) exhibits 
two distinct localized surface plasmon resonances, corresponding to the two unique 
modes of electron oscillation along transverse and longitudinal directions. The absorption 
cross-section of the prolate spheroid is derived from Mie theory by Richard Gans and 
expressed as follows [150, 151]:     
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Where, the sum over j involves the three dimensions of the nanorod. Pj (that 
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As evident from (5-2), the depolarization factor along the longitudinal direction 
(PA) exhibits a strong dependence on aspect ratio and decreases sharply with increasing 
aspect ratio.  The reduction in the restoring force for the longitudinal plasmon mode with 
increase in the aspect of ratio of AuNR results in lowering its resonance frequency (or 
increasing LSPR wavelength). Thus, the longitudinal plasmon band of AuNR is highly 
sensitive to the aspect ratio of AuNR. In aqueous solution, the longitudinal plasmon 
resonance wavelength (λmax) is linearly proportional to the aspect ratio (R) and given by 
the following relationship [152, 153]: 
.42095max  R                                                (5-5) 
Therefore, we can tune the longitudinal plasmon resonance wavelength matching with the 
PC resonance by tuning the aspect ratio of a gold nanorod. 
5.2.2  Electromagnetic Modeling Using FDTD 
The modeling of the electromagnetic field distribution around plasmonic 
nanorods is performed using 3D finite-difference time-domain (FDTD) technique with 
commercially available software (EM Explorer). FDTD simulations exploit the time and 
position dependence of Maxwell’s equations to model electromagnetic waves in 
rectangular 3D cells of finite volume called Yee cells.  To obtain the electromagnetic 
field distribution, a single AuNR of ~30×30×60 nm
3
 size is modeled in a simulation 
domain of 300×300×200 nm
3
 using p-polarized incident plane wave for illumination with 
Yee cell size of 2 nm. Perfectly matched layer (PML) absorbing boundary conditions are 
applied in all directions. The complex refractive index of gold at the extinction maximum 
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wavelength is set to nAu=0.18+i4.96. The resulting electromagnetic distribution is shown 
in Figure 5.3. 
5.2.3 Gold Nanoparticle Synthesis 
Gold nanorods (AuNR) were synthesized using a seed-mediated approach.  Seed 
solution was prepared by adding 0.6 mL of an ice-cold sodium borohydride solution (10 
mM) into 10 mL of 0.1 M cetyltrimethylammonium bromide (CTAB) and 2.5×10
−4
 M 
chloroauric acid (HAuCl4) solution under magnetic stirring at room temperature.  The 
color of the seed solution changed from yellow to brown.  Growth solution was prepared 
by mixing 95 mL of CTAB (0.1 M), 0.5 mL of silver nitrate (10 mM), 5 mL of HAuCl4 
(10 mM), and 0.55 mL of ascorbic acid (0.1 M) in the same order.  The solution was 
homogenized by gentle stirring.  To the resulting colorless solution, 0.12 mL of freshly 
prepared seed solution was added and aged for two weeks at room temperature.  Prior to 
use, the AuNR solution was centrifuged at 10, 000 rpm for 10 mins to remove excess 
CTAB and redispersed in nanopure water (18.2 MΩ-cm).  The centrifugation procedure 
was repeated twice. 
5.2.4 PC Biosensor Surface Functionalization 
The PC biosensors were functionalized using a vapor-phase aminosilane process. 
The aminosilane chemistry was chosen for its low background and high binding capacity 
to capture antibodies. The biosensors were first cleaned by isopropanol, and deionized 
(DI) water, dried in a stream of N2, and then treated in an oxygen plasma system (Diener, 
Pico) for 10 min (power of 100 W, pressure of 0.75 mTorr). The biosensors were then 
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vertically placed in a glass container. At the base of the container, 100 mL of (3-
aminopropyl)-dimethyl-ethoxysilane (APDMES, Sigma Aldrich, Saint Louis, MO) was 
placed and the top lid was securely placed over the dish. After, the glass dish with the PC 
biosensors was placed in a vacuum oven for an overnight incubation at a pressure of 30 
Torr. After silanization, the biosensors were then washed with toluene, methanol, and DI 
water and dried under a stream of N2. 
5.2.5 AuNR-IgG Conjugates on PC Biosensor Surface 
To a solution of heterobifunctional polyethylene glycol (SH-PEG-COOH) in 
water (37.5 μL, 20 μM, Mw = 5000 g/mol, Jenkem Technology), 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC, Thermo Scientific), and N-hydroxy 
succinimide (NHS, Thermo Scientific) with the same molar ratio as SH-PEG-COOH 
were added followed by shaking for 1 hour.  The pH of the above reaction mixture was 
adjusted to 7.4 by adding 10× concentrated phosphate buffered saline buffer solution, 
followed by the addition of rabbit immunoglobulin G (IgG) (10 μL, 75 μM, Mw = 150 
kDa, Thermo Scientific).  The reaction mixture was incubated for 2 h, and then filtered to 
remove any byproduct during the reaction using a 50 kDa filter.  The final SH-PEG-IgG 
conjugates solution (0.75 μM) was obtained after washing with phosphate buffered saline 
buffer (pH 7.4) twice.  AuNR-IgG conjugates solution was prepared by adding 50 μL 
SH-PEG-IgG conjugates solution to 1 mL twice centrifuged AuNR solution with 
incubation for 1 hour.  The amount of SH-PEG-IgG was optimized to obtain maximum 
coverage of IgG on AuNR surface.  Then the PC surface was exposed to AuNR-IgG 
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conjugates solution for 30 mins, followed by rinsing with DI water to remove the loosely 
bound nanorods. 
5.2.6 Protein Microarray Printing 
The antibodies (~5.0 mg /mL) where diluted in proprietary printing buffer 
(NanoInk Inc., Skokie, IL, USA); the printing buffer is formulated to keep the protein 
moisturized and to preserve their active and folded states. Each well atop of PC holds 4 
subarrays and the glass slides hold 16 subarrays in a 4×6 format; each subarray contains 6 
sets of 4 replicate spots per antibody for a total of 24 spots. Spot diameters were 
measured to be ~100 µm. The printed substrates were incubated in a sealed box with a 
desiccant for 24 hours at room temperature. 
5.2.7 Nanoparticle Sandwich Immunoassay Assay 
To detect the tumor necrosis factor alpha (TNF-a) antigen, the capture antibody of 
TNF-a with a concentration of 20 ug/mL is first immobilized on a functionalized PC 
biosensor. Then the different concentrations of TNF-a antigen solution is applied to 
biosensor surface. After certain incubation time (e.g. 3 hours in room temperature), the 
PC surface is rinsed off with PBST (0.01% v/v tween 20 in PBS) to remove the unbound 
TNF-a antigen. Then the detection antibody applied on the biosensor surface for 1 hour, 
followed by the incubation of streptavidin linked gold nanoparticles for 30 mins. The 
device is then rinsed by PBST again and then applied with DI water for imaging. 
Next, the slides were placed in a 4-well format with PDMS, where each well 
could hold up to 20 uL. The arrays were blocked with casein blocking buffer (BioRad, 
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Hercules, CA) for 1 h. All incubations were performed at room temperature. The arrays 
were then washed three times with 0.01% (v/v) tween 20 in phosphate buffered saline 
(PBST) and then each well was incubated with a 10 uL mixture of different antigens 
concentration in casein buffer for three hours. This was followed by three rinses in PBST 
after the PC substrates were incubated with 10 uL of the biotinylated detection antibody 
mixture in each PDMS well for 1 h. The PC substrates were then washed three times with 
PBST, followed by the incubation with a 1 ug/ mL solution of nanoparticle conjugated 
streptavidin (Invitrogen) for 30 min. Finally, the devices were washed 5 times with PBST 
and followed by a quick dip in DI water (3 s.) to remove the salt, spin dried, and then 
scanned using PCEM system. 
5.3 Results and Discussion 
5.3.1 Detection of IgG and Anti-IgG Binding 
We studied the biosensor’s ability to detect target bioanalytes binding with 
immobilized antibody on the PC biosensor surface.  To match the PC resonant 
wavelength, we synthesized gold nanorods (AuNR) with resonant optical absorption 
spectra around ~620 nm (Figure 5.4 demonstrates the TEM image of AuNR). The size of 
the synthesized AuNR is 66.7 nm ± 5.5 nm in length and 30.7 nm ± 4.0 nm in diameter 
(as analyzed in TEM images from 56 AuNRs).   
Then we employed Rabbit Immunoglobulin G (IgG henceforth) as model capture 
biomolecule and anti-Rabbit IgG (anti-IgG) as model target bioanalyte to demonstrate the 
detection of antibody-antigen binding (as shown in Figure 5.2) using NP-PCEM. IgG is 
the one of main antibody isotypes found in the human blood and extracellular fluid to 
control body tissues’ infection. It protects the human body from infection through many 
 100 
 
immune mechanisms, such as binding pathogens (e.g. bacteria and viruses) and thus 
allowing their recognition by immune cells. IgG monomer is about 150 kDa and forms a 
tetrameric quaternary structure composed of four peptide chains and arranged in a “Y” 
shape, which contains two identical light chains (about  25 kDa) and two identical heavy 
chains (about 50 kDa). The two heavy chains are linked to each other and each heavy 
chain is linked to a light chain with disulfide bonds, which forms a shape of a “fork” 
containing an identical antigen binding site. In clinic, IgG can be measured and therefore 
considered as a diagnostic tool for certain diseases, such as hepatitis B virus, chickenpox, 
or mumps, etc.  
Figure 5.5 illustrates the binding of biomolecules to target bioanalytes attached to 
the PC biosensor surface.  In this setup, thiol-terminated polyethylene glycol (SH-PEG), 
a hydrophilic polymer, serves as a flexible linker to increase the accessibility of IgG to 
target bioanalyte [154, 155].  The AuNR-IgG conjugates were prepared by 
functionalizing AuNRs with SH-PEG-IgG molecules.  Subsequently, anti-IgG was 
adsorbed onto the PC biosensor surface by exposing the PC to anti-IgG solution followed 
by thorough rinsing with PBS to remove the weakly adsorbed antibody.  Exposing the PC 
surface to AuNR-IgG conjugates resulted in specific binding to anti-IgG (SEM images 
shown in Figure 5.6), which can be detected as a PIV reduction in the area absorbed with 
AuNR.  Figure 5.7(a) shows the mathematical difference between two PIV images taken 
before and after AuNR-IgG attachment and selected cross-section lines in the PIV images 
(Figure 5.7(b)).  It demonstrates that PCEM can successfully detect the intensity 
reduction in presence of AuNR-IgG. 
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5.3.2 PCEM Imaging with Microarrays of Cancer Biomarkers 
A microarray is a large array of small biological material spots bound to the 
functionalized substrate surface. Each of the spots contains different capture molecules 
and the then probe molecules, typically tagged with a fluorescent dye, can be added to the 
array to indicate the protein-protein interactions or gene expressions. Therefore, 
microarray can perform high-throughput tracking of interactions and activities of proteins 
or DNAs and hence achieve rapid and economical detections while only consuming a 
small amount of samples and reagents. Sandwich antibody microarray has been reported 
to use a small amount of sample (e.g. 3~10 µl) to detect low concentrations of analytes 
(e.g. ~10 pg/ml) [38, 39]. It also demonstrates the detection capability of fast binding 
kinetics, lacking of assay cross-reactivity, and providing lower limits of detection.  
However, conventional protein microarrays can generally only be scanned a few times 
after the label step due to the utilizing of fluorescent dye as reporters, and thus it lacks of 
capability to capture kinetics information.  Besides, it requires the exposure of capture 
antibody array to the test sample solution for a long period of time, especially for 
detection of low detection limits range (e.g. 1~10 pg/ml).  Recently, protein microarrays, 
together with the use of photonic crystal biosensors to enhance fluorescence, have been 
shown to extend the detection limits down to the range of 0.1~1 pg/ml in our lab [156]. 
We next printed the microarray of biotinylated detection antibody (anti-TNF-a) 
with a concentration of 10 ug/ml on the photonic crystal biosensor surface. After a certain 
time of incubation (e.g. 24 hours), the unbound antibody is rinsed off from the biosensor 
surface. Then, the NHS linked gold nanoparticle solution is exposed to the biosensor 
surface. To compare the detection results, a control experiment is performed with a 
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similar procedure, except utilizing streptavidin linked Cy5 fluorescence dye (10 ug/mL) 
to tag the detection antibody. The measured printed spot size is around 100 um in 
diameter and the resulting peak intensity and wavelength shift images images are shown 
in Figure 5.8. 
5.3.3 Detection of Cancer Biomarkers with Sandwich Assay 
Next, we performed an antibody-antigen-antibody sandwich immunoassay to 
verify the PCEM detection performance tagged with nanoparticles. As shown in Figure 
5.9, the proposed antibody-antigen-antibody binding detection modality using (NP-
PCEM) can be decomposed into the following steps: (1) the capture antibody (or primary 
antibody) is immobilized on the photonic crystal biosensor surface; (2) the target antigen 
solution is applied on the biosensor surface and will be captured by the capture antibody; 
(3) then the solution of detection antibody (secondary antibody) is applied to the mixture 
solution in step 2 to bind with the antigen; (4) finally the gold nanoparticles are applied to 
the mixture solution in step 3.  
Detection of tumor necrosis factor alpha (TNF-a) is demonstrated in this section 
as an example. TNF-a is an adipokine involved in systemic inflammation and can be 
produced by activated macrophages.  It is also an endogenous pyrogen and can regulate 
the immune cells through inducing fever, cell apoptosis, or inhibiting tumorigenesis. 
TNF-a contains 212 amino acids and is a cellular transmembrane protein which can 
activate the NF-κB and MARK pathways or induce death in cell signaling pathways. 
Failure of normal TNF-a regulation can lead to severe diseases, such as cancer, 
depression, Alzheimer’s disease, just to name a few.  
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Photonic crystal biosensors were mounted with the PDMS well and four replicate 
microspots with capture antibodies for TNF-a were printed on the biosensor surface in 
each well using a nanoplotter system. A TNF-a antigen was assayed in these wells over a 
range of 6 concentrations (in a 3-fold dilution series) starting with 0.1 ng/mL. PIV images 
for the nanopartile were acquired using the PCEM imaging system, as shown in Figure 
5.10. Figure 5.11 demonstrates the dose-dependent response of each antigen assays. 
Currently the lowest concentration of TNF-a detected on the PC surface was about 10 
ng/mL. The results demonstrate that NP-PCEM can successfully detect the dose-
dependent response of the target antigen. However, the low concentration response lacks 
of accuracy and it is likely due to the linker (NHS) between the gold nanoparticle and the 
detection antibody is not specific binding. This non-specific binding may result the 
binding of nanoparticle with the capture antibody. Future work can be extended to switch 
the non-specific linker to linker between a pair of specific molecules. For example, biotin 
and streptavidin which are known having one of the strongest non-covalent interactions 
in nature, can be used as a pair of linking proteins to link between the detection antibody 
and the gold nanoparticle. 
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5.4 Figures 
 
 
 
Figure 5.1  The Schematic Diagram of PCEM detection of protein-protein binding.   
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Figure 5.2  The Schematic Diagram of Protein-protein Binding Method using (NP-
PCEM):  The probe protein (e.g. Anti-IgG) is immobilized on the photonic crystal 
biosensor surface. Then the target protein (e.g. IgG) is tagged with the gold nanoparticles 
and applied on the biosensor surface and will be captured by the probe protein. After 
incubation of the tagged target protein on PC surface, the unbound target protein is rinsed 
off and the remaining nanoparticles can be countable for protein-protein events. 
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Figure 5.3  The result  of computer simulation for electromagnetic distribution of a 
single nanorod. 
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Figure 5.4  Transmission electron microscopy (TEM ) images of synthesized gold 
nanorods (AuNR). 
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Figure 5.5  UV-vis extinction spectra confirm the conjugation between AuNR and SH-
PEG-IgG. 
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Figure 5.6  Scanning electron microscope (SEM) images of AuNR-IgG attached on PC 
biosensor surface. Inset: Zoomed in SEM image. 
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Figure 5.7  PCEM detection of protein-protein binding. (a) PCEM detected PIV images 
(in gray scale) for the difference between without and with AuNR-IgG on PC surface. (b) 
Two representative cross-section lines of the normalized intensity images for without and 
with two AuNRs-IgG on PC surface. 
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Figure 5.8  PCEM detection of anti-TNF-a with nanoparticles in printed microspots (a) 
peak intensity change  (in gray scale) and (b) peak wavelength shift images. 
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Figure 5.9  The Proposed Protein-protein Binding Method using (NP-PCEM). (a) the 
capture antibody is immobilized on the biosensor surface; (b) the target antigen solution 
is applied on the biosensor surface and will be captured by the capture antibody; (c) the 
solution of gold nanoparticles tagged detection antibody is applied on the sensor surface;  
(d) The detection antibody bind with the antigen; (e) Rinse off the unbound detection 
antibody. 
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Figure 5.10  PIV images for the nanoparticle were acquired using the PCEM imaging 
system. 
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Figure 5.11  The dose-dependent response of each  TNF-a antigen assays detected using 
PCEM system. 
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CHAPTER 6 
CONCLUSIONS AND FUTURE OUTLOOK  
 
6.1 Conclusions 
Our group has previously proposed the use of photonic crystal as a versatile 
biosensor.  In this work, we applied this tool to imaging of live cells, nanoparticles and 
protein-protein binding.  In the process, we have extended the acquisition system to adapt 
to the specific requirements of each problem.  Namely, we have integrated bright-field 
imaging for cell imaging (crucial to validate the detection of adhering cells), reduced the 
acquisition time by optimizing the scanning procedure and developed image analysis 
tools to allow the calculation of quantitative measurements (cell displacement and 
nanoparticle counting).  Results from live-cell imaging suggest that the photonic crystal 
can successfully detect live cell during adhesion, migration and differentiation. The 
temporospatial analysis software offers movel measures of the dynamic change of cell 
plasma membrane during cellular activity. Owing to the narrow spectra resolution and 
short lateral propagation, photonic crystal biosensor is able to detect the particles in 
nanometer scale without any labeling. This novel technique can be utilized to detect 
protein-protein binding (tagged with nanoparticle) while avoiding the photobleach issue 
which would otherwise appear if using fluorescence tagged biosensing techniques. Each 
of these studies is a stepping stone towards to the ultimate goal of sensing for biological 
phenomena and it is expected to provide guidance to the future development of the 
biosensing technology. 
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6.2 Future Outlook 
One of the ultimate goals of a biosensor is to detect or monitor the interaction 
among biological samples in their nature format with high sensitivity. Photonic crystal 
biosensor shows great promise to this goal and can potentially serve as the candidate for 
the next generation biosensing modality. The experimental results and the imaging 
analysis in this dissertation make a strong case for the application of the photonic crystal 
enhanced microscopy as an ideal scheme for biosensing and bioimaging, especially for 
live cell imaging and protein-protein binding detection. Nevertheless, there is room for 
the further improvement of the PCEM imaging system, such as: 
- Improving the signal-to-noise ratio: 
The signal in label-free nanoparticle detection, due to the presence of reacting 
particles on the top of the surface, currently measured at the output spectrometer is 
degraded by noise, which can sometimes have a comparable level with the signal itself.  
Therefore, any improvement in the imaging contrast, including changes to the optical 
light path, would result in a net gain in system’s accuracy.  
-  Integration of multi-illumination and imaging modality: 
Iin order to validate the results from cell-imaging, it would be useful to have the 
ability to combine fluorescence and label-free PCEM imaging of the same cell 
simultaneously.  
- Continued improvements to the imaging acquisition and analysis software:  
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While the current tools proved satisfactory for this work, cell tracking could 
benefit from more robustness. If the spline mapping operation can be improved, the level-
set method would not be necessary and thus resulting in faster boundary tracking.  
Similarly, the nanoparticle counting procedure is limited when dealing with clustered 
nanoparticles.  Such case are typically challenging segmentation problems, for which 
extensive research has be done, advanced methods may therefore be applied to improve 
the robustness of the imaging and analysis system. 
Future applications will incorporate the above points and further advance the 
photonic crystal enhanced microscopy system. 
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